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Abstract
External beam radiotherapy has become technically sophisticated with image guided radiation
therapy (IGRT) and intensity modulated radiation therapy (IMRT). These technologies allow
for precise delivery of radiation to geometric targets in cancer patients. However, many ques-
tions remain on how to best define targets based on biological information, such as functional
imaging, and how to combine radiation with other cancer therapies. To help answer these
questions, small animal preclinical studies are needed to generate data to inform clinical trials.
However, the precise radiation delivery capabilities of IGRT and IMRT have not been available
in the preclinical labs. To enable translational experiments and to address the lack of preclini-
cal radiotherapy technology, a commercial micro-CT was first developed into an image-guided
conformal radiotherapy system in this thesis. Computerized asymmetric jaws were constructed,
implemented and characterized for the system. A Monte Carlo dose calculation package was
successfully configured for the system and verified with film measurements. Respiratory gated
imaging and radiotherapy was demonstrated with a phantom and in animals. Secondly, accurate
radiation dosimetry reduces uncertainties in preclinical experiments. To achieve accurate dose
calculations in the kilovoltage x-ray range where photoelectric effects and Compton scattering
dominate, knowledge of material composition and density is needed. Dual energy micro-CT
was optimized (including choice of x-ray beam peak voltages, filtrations, and duration) and
evaluated for the purpose of characterizing materials. Dual energy CT techniques developed
for clinical scanners were adapted and examined for micro-CT. A set of micro-CT phantoms
consisting of 11 plastic materials and solutions that spanned a relevant range of compositions
was designed and constructed. Initial experiments found beam-hardening image artefacts lim-
ited accurate measurements. By switching to a more sensitive detector, x-ray spectra with
additional beam filtration were possible and resulted in reduced beam-hardening effects. This
improved dual energy micro-CT measurement accuracy of material composition and density.
In conclusion, a small animal image-guided conformal radiotherapy system was developed and
commissioned for preclinical studies. Dual energy micro-CT was demonstrated as a method to
ii
characterize materials to improve kilovoltage dose calculation. This integrated micro-CT based
small animal image-guided radiation platform has enabled numerous pre-clinical studies.
Keywords: Small animal image-guided radiation therapy, dual-energy x-ray micro-computed
tomography, micro-CT
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Chapter 1
Introduction
1.1 Cancer
Cancer is a class of diseases characterized by uncontrolled cell growth. Mutations are changes
in the information encoded in the DNA of the cell that can cause the overexpression of pro-
growth oncogenes, or inactivation of tumour suppressor genes. When the balance between
oncogenes and tumour suppressors is sufficiently upset to favour oncogenes, the cell can con-
tinuously divide. The cells can gain several additional characteristics through succeeding mu-
tations and acquire an invasive cancer phenotype. The characteristics of metastatic cancer are
often described as the Hallmarks of Cancer, proposed by Hannah and Weinberg.1,2
Cancer is prevalent in Canadian society, with 45.1% of men and 41.4% of women predicted
to be diagnosed within their lifetime.3 The survival rates for cancers vary greatly, even among
some of the most common cancers. The Canadian five-year relative survival rate for breast
cancer is 88%, contrasted to 17% for lung cancer.3
1.2 Treatments for Cancer
The treatment of cancer can broadly be divided into three categories: surgery, radiation therapy,
and systemic therapy (chemotherapy, biologic therapy).4–8 Surgery is often the preferred treat-
ment for early localized disease, i.e. cancers that have not spread to either local lymph nodes or
1
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more distant organ sites.4 Radiation therapy is frequently used for locally advanced disease, ir-
radiating both the primary tumour and surrounding tissue, and lymph nodes that likely harbour
undetected cancer cells.5 In some instances, radiation therapy can be the primary treatment for
early localized disease. For example, early and moderately advanced laryngeal cancer can be
initially treated with radiation therapy with the more invasive laryngectomy reserved for re-
lapse.9 Systemic therapies, such as chemotherapy, are used to treat systemic disease that has
spread to distant sites.6,8 The three treatments are often combined to provide a treatment pro-
tocol optimized for each cancer type and stage. For example, radiation and chemotherapy can
be administered to reduce the tumour bulk prior to surgery, or after surgery to combat residual
occult disease.4–6,10
Traditional chemotherapeutics have been cytotoxic compounds that preferentially kill di-
viding cells.6,11 Hence they kill cancer cells, but also normal replicating cells such as hair,
gastrointestinal, and haematopoietic cells.6,11 The death of normal cells results in many of the
adverse reactions of these drugs.6,11 Newer targeted pharmaceutical compounds have been de-
veloped to interfere with specific cellular pathways associated with cancer and are aimed at
reducing collateral toxicity.8,11
1.3 Development of radiation therapy
Development of radiation therapy for the period after the Second World War has been primar-
ily one of technological advancement.12–17 While it is known that fast growing cells, such as
cancer, tend to be more sensitive to radiation and cytotoxic chemotherapy than slower growing
cells, radiation can be spatially confined unlike a systemic drug.11 Therefore, one of the over-
arching goals of radiotherapy development for the past several decades has been to increase
the accuracy and precision with which ionizing radiation can be delivered to targeted regions
in cancer patients.12,16,18 Improved anatomical imaging by CT and MRI allowed improved ac-
curacy through better target identification and localization during treatment planning.12,13,19,20
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Figure 1.1: Photo of a modern linear accelerator (linac) equipped with kilovoltage onboard x-
ray imaging (∗), electronic portal dosimeter (megavoltage imaging) (†) and multileaf collimator
(‡). All imaging components are retracted in (a). Imaging devices are all extended around a
mock patient in (b). The multileaf collimator can produce many complex shapes, including
letters (c)
Collimation technologies combined with image guidance during therapy have allowed for in-
creased precision in radiation delivery to targeted zones.15,16
1.3.1 Image guidance in radiation therapy
The addition of an imaging system to the radiation treatment unit allows for the patient to
be imaged prior to therapy that often spans weeks of daily treatments. Many linear accel-
erators (linacs) come equipped with on-board x-ray imaging and electronic portal dosimeter
(figure 1.1).15,20 This allows for 2D static radiographs (figure 1.2), 2D motion fluoroscopy and
3D cone-beam CT (figure 1.3).13,15,20,21 The pre-treatment or images concurrent with treatment
are used to correct patient setup errors or monitor position during treatment.13,20,22 In addition
to improving the accuracy of conventional radiation therapy, image guidance enables the tar-
geting confidence required for advanced techniques like stereotactic radiosurgery with ablative
radiation doses.15,16
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Figure 1.2: Digitally reconstructed radiographs derived from CT used in treatment planning
compared with projection kV images acquired prior to a therapy session. The anterior and
lateral views are used to correct patient positioning by aligning skeletal or target landmarks in
all dimensions. Courtesy Dr. J. Chen.
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Figure 1.3: The planning CT image (lighter) is compared with the cone beam CT (darker).
The cone beam CT acquired prior to treatment (using the onboard kilovoltage x-ray system) is
aligned or registered with the planning CT to correct the patient position using both skeletal
and soft tissue features. Courtesy Dr. J. Chen.
Chapter 1. Introduction 6
Figure 1.4: Intensity Modulated Radiation Therapy (IMRT) treatment plan for a head and
neck cancer patient displayed with transverse (a), coronal (b) and sagittal (c) views. Dose is
displayed as a colourwash overlaid on the CT images. The three concave targets surrounding
the brain stem are treated to different dose levels using intensity modulation and multiple beam
directions. Concurrently, the dose is minimized to healthy organs, such as the brain, brain stem,
spinal cord, parotid gland and mandible. Scale bar is 2 cm. Sample IMRT plan data from the
Computational Environment for Radiotherapy Research (CERR) www.cerr.info
1.3.2 Intensity modulation in radiation therapy (IMRT)
Conforming the radiation dose to complex anatomical structures that may be concave required
the development of complex beam shaping hardware and treatment planning software.15,16,18
A collimation device, called a multi-leaf collimator (MLC) is shown in figure 1.1c. Inten-
sity modulation allows the precise delivery of a uniform radiation dose to a complex shape at
depth in the patient.16,18 By shaping and confining the therapeutic dose to the targeted cancer,
the surrounding health structures can receive lower doses and treatment complications can be
minimized in normal tissues.23 An IMRT treatment plan for a head and neck cancer patient
is presented in figure 1.4. The concave targets are irradiated with different dose levels while
minimizing dose to healthy structures.
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1.4 Next generation radiotherapy: biological targeting
The technical development of radiation therapy has achieved remarkable accuracy and preci-
sion in depositing radiation dose in a geometric sense.12 However, questions remain on how
best to use this very accurate and precise tool if the target is delineated with much uncer-
tainty.12 To do so requires further understanding and exploitation in cancer radiobiology, such
as biological target volumes proposed by Ling et al.24 or dose painting.25 While radiother-
apy has progressed on a technological path, concurrently the understanding of cancer biology
has greatly improved. Currently, pharmaceuticals are being developed to act on specific tar-
gets of cancer cells.8,26 Genome sequencing allows for the identification of specific mutations
in cancers.27 Molecular imaging allows the probing of the biological entities and their func-
tion in patients.28,29 This wealth of biological information has not been fully exploited in the
treatment of cancer with targeted therapy.20,26 Genome information is used to identify patients
who are likely or unlikely to respond to new targeted drug therapies. For example, the drug
vemurafenib targets the mutant B-Raf protein (V600E or V600K), part of a pathway that me-
diates cell growth signals.30 Many melanomas have mutated BRAF genes,31 and a clinical
trial demonstrated identifying melanoma patients with the V600E or V600K mutant variant of
BRAF and treating with vemurafenib.32 However, radiation therapy has been slower to utilize
this new biological information. As new surgical techniques and pharmaceutical compounds
become available, their combination with radiation therapy will need to be optimized to “hit”
tumour cells more specifically and spare normal cells.26
1.5 Benefits of preclinical irradiation studies
Drug development is heavily dependent on preclinical animal studies to evaluate the effective-
ness and safety of candidate drug compounds. Preclinical animal studies provide a complex
living system to test any new therapeutic agent under well controlled conditions, allowing
cost-effective, intensive and invasive data collection not ethically possible during human clin-
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Figure 1.5: Example DCE-CT blood flow images of a subcutaneous xenograft hypovascular
human colon tumour (LoVo) treated with an anti-angiogenic drug (Vandetanib) and followed
for 6 days. A reduction in the blood flow in the rim of the tumour is observed over the treatment
period (white arrow). Courtesy Drs. J. H. Tai and T.-Y. Lee
ical trials. The potential drawback of the down-scaled experiments is that the animal model
may not mimic the human situation.33
An example preclinical trial is briefly presented. Tissue hemodynamics can be measured
with dynamic contrast enhanced CT (DCE-CT).34 The hemodynamic characteristics of the tu-
mour at diagnosis and how it changes over the course of therapy are potential prognostic and
predictive biomarkers.35 While DCE-CT images have been acquired as part of clinical trials,
the frequency of imaging cannot match that possible in a preclinical trial. A preclinical inves-
tigation with an anti-angiogenic drug treatment monitored by frequent DCE-CT is presented
in figure 1.5. Radiation therapy development has not traditionally used preclinical studies,
because the objective of improving dose conformity and targeting accuracy was deemed self-
evident and did not require preclinical evidence to justify a clinical trial. As the focus is
shifting to biologically-targeted radiotherapy, preclinical studies with animals are needed
to generate evidence to support clinical trials.
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Figure 1.6: Irradiation of the right lung of a rat with a cobalt-60 source from below at the
London Regional Cancer Program. The rat was anesthetized with isoflurane and held in a
restraint box above the beam aperture. A radiochromic film was placed on the rat (yellow) to
verify the radiation field location after irradiation (black semi-circle). Two parallel-opposed
beams were delivered by first irradiating the animal in the prone position (a) and then rotating
the restraint box so the rat was in the supine position (b). Photo credit: Dr. E. Wong.
1.6 Current small animal irradiator technology
1.6.1 Whole body irradiators (x-ray, radionuclide)
Laboratory irradiation of animals has traditionally been simple.36 Often the irradiation study
only required gross targeting, if any targeting at all. Many studies irradiated the entire animal,
or a large portion, such as half the animal or a limb. Collimation of the field when present is
usually done by using shaped lead blocks that are manually placed.37,38 Whole body irradia-
tor cabinets containing a radioactive or x-ray source are often used for bone marrow ablation
studies. These can be used for radiation therapy studies also by adding lead shielding above
the animal. However, this setup lacks any image guidance to visualize sub-dermal targets.
Irradiation devices from the clinic have been adapted for small animals. This can vary from
using superficial x-ray units and cobalt-60 sources to state-of-the-art linear accelerators. The
simpler approaches, like a superficial unit39 or cobalt source are similar to the irradiator cabinet
with no image guidance and complex lead shielding. Locally at the London Regional Cancer
Program, an old cobalt-60 source has been used for small animal irradiation, as shown in fig-
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ure 1.6. Advanced linear accelerators are sized for irradiating human patients, so while they
have image guidance and advanced beam collimation, adaptation to the sizes of small animals
is challenging. Often even with an advanced accelerator, the irradiation plan is simplified to
whole or partial body irradiation.40
1.6.2 Image guided conformal irradiators
Several research investigators have developed image-guided conformal irradiators specifically
for small animal studies. The 2011 review by Verhaegen el al.36 covers the development of
a number of preclinical irradiators. This section will concentrate on two systems that were
commercialized and a third system more closely related to the work presented in this thesis.
Table 1.11 provides an overview of the system capabilities.
1.6.2.1 Small Animal Radiation Research Platform (SARRP)
The Small Animal Radiation Research Platform (SARRP) (figure 1.7) was originally developed
at Johns Hopkins University (Baltimore, MD).41,42 This was one of the first complete systems
reported in the literature for image-guided conformal irradiation. Since the initial publication,
the system has undergone extensive development resulting in a mature commercial product
now currently sold by XSTRAHL Ltd. (Surrey, UK). The mechanics of the SARRP allow for
many non-coplanar beam directions, as the animal couch allows for translation in 3 dimensions
and rotation. CT acquisition is dependent upon rotation of the couch, but the gantry rotation
is restricted and the imaging detector is stationary. The x-ray tube and generator is capable of
operation up to 225 kVp and is used as both the imaging and therapeutic source. The initial
design was unshielded and required lead curtains or a shielded room. Subsequent commercial
development added a self-shielding cabinet, as well as an additional portal imaging detector
placed on the beam exit side of the animal. A planning system (Muriplan) is commercially
available. Recently, a symmetric jaw collimator and respiratory-gated shutter system became
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SARRP X-Rad 225Cx Stanford
(Johns Hopkins) (Toronto and University
Masstricht)
Maximum accelerating 225 225 120
potential (kVp)
Interchangeable beam Yes Yes No
filters
Dose rate (Gy/min) 4 4 2
Collimation Fixed cones Fixed cones Computerized
(Jaw option variable aperature
recently available)
Field sizes Circular and Square Circular and Square Pseudo-circular
0.5 mm  – 1.0 mm  – 0.1 – 6 cm 
10 mm × 10 mm 10 mm × 10 mm
Beam direction non-coplanar coplanar coplanar
Asymmetric/off-axis fields No No No
Stage translation 3D + rotation 3D 3D (contrained
by CT bore)
Respiratory Gating No (Gated shutter No No
option recently available)
Image resolution (µm) 130 200 49
Targeting accurracy (µm) 200 200 100
Dose calculation and Muriplan SmART-Plan RT Image
planning system (Commericial) (Maastro Clinic, (Stanford, in-house)
Commercial)
Table 1.1: Comparison of select image-guided small animal irradiation systems.
Chapter 1. Introduction 12
Figure 1.7: The first version of the SARRP system. “Small animal radiation research platform
(SARRP) with conformal irradiation and cone-beam computed tomography guidance capabil-
ities. Maximal extent of system measures 3 ft. wide, 4 ft. long, and 6 ft. tall. It is equipped
with wheels for ease of transport but rests on stops for stationary use. Camera-based electronic
imaging system has since been replaced with a 21-cm × 21-cm flat panel amorphous silicon
detector.” Reprinted from Int. J. Radiat. Oncol. Biol. Phys., 71(5), J. Wong, E. Armour, P.
Kazanzides, I. Iordachita, E. Tryggestad, H. Deng, M. Matinfar, C. Kennedy, Z. Liu, T. Chan,
O. Gray, F. Verhaegen, T. McNutt, E. Ford, and T. L. DeWeese, “High-Resolution, Small An-
imal Radiation Research Platform With X-Ray Tomographic Guidance Capabilities”, 1591–
1599, Copyright (2008), with permission from Elsevier. doi:10.1016/j.ijrobp.2008.04.025
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Figure 1.8: “Pictures of the micro-IGRT (X-Rad 225Cx) unit. (a) The exterior of the
self-shielded cabinet. (b) Interior, showing the C-arm setup with collimator and 3D lin-
ear translation stage. (c) Geometry of the system, with dSAD = 30.7 cm, dSDD = 64.5 cm,
and dSCD = 23 cm. The primary beam is collimated to cover the entire detector surface
(Dwidth × Dlength = 20.4 × 20.4 cm2), giving a FOVz = FOVxy = 9.7 cm.” Reprinted with
permission from R. Clarkson, P. E. Lindsay, S. Ansell, G. Wilson, S. Jelveh, R. P. Hill, and
D. A. Jaffray, Med. Phys. 38, 845–856 (2011). Copyright 2011, American Association of
Physicists in Medicine. doi:10.1118/1.3533947
available after the second chapter of this thesis was published.17 However, demonstrations of
these new SARRP accessories have not yet been documented in the literature.
1.6.2.2 Toronto System
The group at Princess Margaret Cancer Centre (Toronto, ON) developed the X-Rad 225Cx in
partnership with Precision X-Ray Inc. (North Bradford, CT). Depicted in figure 1.8, the X-Rad
225Cx is based on a C-arm geometry, restricting treatment beams to a coplanar geometry.43 CT
image acquisition is more conventional, with a fully rotating x-ray source and detector. Similar
to the SARRP, the X-Rad 225Cx uses a 225 kVp x-ray tube and generator for both imaging
and therapy. Additionally, this system comes with a self-shielded cabinet.
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1.6.2.3 Maastricht System
The group at Maastricht University Medical Center (Maastricht, Netherlands) purchased a X-
Rad 225Cx system and developed a number of enhancements. Electronic portal imaging de-
vices (EPIDs) have been used to measure the therapeutic radiation beam exiting the human
patient to verify the dose delivered during therapy.44 The Maastricht group brought EPID ver-
ification dosimetry to small animal radiotherapy.45 They modified a Monte Carlo code to con-
tinue particle transport beyond the irradiated object and scored them on a plane corresponding
the EPID. The virtual portal dosimetry images were compared to film measurements with an
agreement within 5% for fields larger than 4 mm. Another contribution was a fast analytical
source model to generate particles for Monte Carlo dose calculations.46 Monte Carlo modelling
of the x-ray tube and collimators for the small fields desired for small animal therapy remain a
challenge. The fast analytical source model was developed to investigate improved collimator
design and faster dose calculations for treatment planning. A small animal treatment planning
system (SmART-Plan) was developed and validated at Maastricht and is now available as a
commercial product sold by Precision X-Ray Inc.47
1.6.2.4 Stanford System
The Stanford group took a different approach, and instead of building a new radiotherapy sys-
tem from scratch, decided to modify a micro-CT into an image-guided irradiator.48,49 The bene-
fit of this approach is that most of the system components and functionality is pre-existing, and
only a few additions and modifications are required. The main addition was the construction of
a computerized collimator (figure 1.9) that allowed for arbitrarily-sized dodecagonal (twelve
sided) fields that are referred to as pseudo-circular fields.50
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Figure 1.9: Computerized collimator of the Stanford micro-CT/RT system. “The variable-
aperture collimator in the microCT/RT system uses two disks with hexagonal shape that open
and close like an iris camera. The disks are rotated 30° one with respect to the other to
form a field of dodecagonal shape.” Reprinted from Phys. Med. Biol. 54 (2009) 3723–
3740, M. Rodriguez, H. Zhou, P. Keall, and E. Graves, “Commissioning of a novel mi-
croCT/RT system for small animal conformal radiotherapy”, © Institute of Physics and En-
gineering in Medicine. Reproduced by permission of IOP Publishing. All rights reserved.
doi:10.1088/0031-9155/54/12/008
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Figure 1.10: Collimators for the SARRP system. “(a) Tertiary brass collimation inserts with
dimensions of 30 mm × 30 mm, 3 mm × 3 mm, and 0.5 mm diameter for small animal radi-
ation research platform. (b) Radiosurgery-like collimating cone assembly attached to primary
collimator of the small animal radiation research platform for small field irradiation (<5 mm ×
5 mm in dimension).” Reprinted from Int. J. Radiat. Oncol. Biol. Phys., 71(5), J. Wong, E. Ar-
mour, P. Kazanzides, I. Iordachita, E. Tryggestad, H. Deng, M. Matinfar, C. Kennedy, Z. Liu, T.
Chan, O. Gray, F. Verhaegen, T. McNutt, E. Ford, and T. L. DeWeese, “High-Resolution, Small
Animal Radiation Research Platform With X-Ray Tomographic Guidance Capabilities”, 1591–
1599, Copyright (2008), with permission from Elsevier. doi:10.1016/j.ijrobp.2008.04.025
1.6.3 Current challenges in small animal irradiation
With the development of various hardware platforms for image-guided conformal small animal
irradiation, several challenges remain.
1.6.3.1 Conformity, intensity modulation, planning
The commercial irradiator systems available are limited by their simple beam shaping. The set
of fixed cones (figure 1.10) that are manually changed limit the conformal abilities of a single
beam. Unlike the multileaf collimators of clinical linear accelerators that can create complex
shapes, these commercial preclinical systems are constrained to pre-set circular and square
fields. The Stanford system can create any arbitrarily sized dodecagonal (pseudo-circular)
field allowing more flexibility, but still is quite limited compared to a clinical system. The lack
of beam-shaping hardware limits the options for implementing intensity modulation on a small
animal. While a small pencil beam could be scanned to create a complex intensity pattern, it is
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less efficient than a single shaped field. In addition to beam-shaping hardware, there is no so-
phisticated small animal treatment planning system. The previously mentioned Muriplan and
SmART-Plan are visualization and analysis platforms for forward planning and dose calcula-
tion. They currently are not capable of inverse-planning complex intensity modulation delivery
plans as is the case in human irradiation.
In the clinical realm, many techniques for managing respiration, such as gating and breath
coaching techniques have been investigated and applied.21,51 Similar respiratory motion man-
agement techniques for small animals have largely been unexplored.
1.6.3.2 Dose calculation with kV energies
Small animals irradiation systems use kilovoltage x-ray sources because this energy is suffi-
cient for penetrating the small size of the animals.36 Clinical systems use more penetrating
megavoltage beams to be able to treat internal tumours to sufficient dose without depositing
toxic doses closer to the surface. However for small animals, especially mice, megavoltage
beam characteristics are less suitable and could potentially under-irradiate tumour portions at
shallower depths; the dose build-up region of a megavoltage beam could be more than half
the thickness of a mouse!36 The build-up and scatter characteristics of a kilovoltage beam are
therefore more suitable for small animals.36 The drawback of a kilovoltage beam is the pro-
portion of photoelectric absorption in the dose deposition. For a megavoltage beam, the vast
majority of dose deposition is by incoherent (Compton) scattering, requiring only knowledge
of electron density to compute dose deposition. At kilovoltage energies, accounting for pho-
toelectric absorption is necessary, requiring knowledge of both the atomic composition and
electron density to compute dose accurately. Figure 1.11 illustrates the differences in mass
energy-absorption for three tissues at varying photon energies.52 This suggests the need for
dual energy CT imaging that can produce maps of electron density and atomic number.53
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Figure 1.11: Mass Energy-Absorption Coefficient (MEAC) for three ICRU-44 tissues: adi-
pose, skeletal muscle and cortical bone. The MEAC is closely related to absorbed radiation
dose. At kilovoltage energies below 225 kVp the MEAC differs between the three tissues due
to photoelectric absorption, which is dependent on the chemical composition of the tissue. To
calculate the dose accurately at kilovoltage energies, both the density and chemical compo-
sition of the tissue is needed. For comparison, at the cobalt-60 energies, the MEAC differs
little between the three tissue types and only density information is needed. The chemical
composition has negligible effect on the dose at megavoltage energies. Data from Hubbell and
Seltzer.
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Monte Carlo dose calculation techniques are generally recognized as the most accurate
dose computation method.54 This method models individual particles interacting with atoms in
materials in a given geometry.
1.7 Dual-Energy Computed Tomography
Signal in a kV x-ray image is dependent upon two factors, the electron density (e per cm3) and
the atomic number of the interrogated tissues. If imaging at a single energy, or fixed energy
spectrum, and only measuring an integrated transmission value, it is not possible to distinguish
a high density low atomic number material from a low density high atomic number material.
One way to distinguish these two cases is to use two energies, or modified spectra. Dual energy
computed tomography (DECT) acquires two image sets at two different x-ray energies. Using
the information from images at two energies, it is possible to distinguish the high density low
atomic number material from a low density high atomic number material.55,56
1.8 Research Goals and Objectives
The research goal of this thesis was to develop the technology and techniques in small animal
image-guided radiation therapy to address some of the challenges identified in the previous
sections (i.e. maximum animal size, complex collimation, beam gating, dual-energy CT for
Monte Carlo dose calculation). The specific aims included:
1. Develop a system with asymmetric fields that could treat off-axis tumours in rats
2. Gated therapy for irradiation of thoracic and abdominal tumours
3. Commission the micro-CT/RT irradiator and Monte Carlo dose calculator
4. Dual energy micro-CT to measure effective atomic number and relative electron density
for more accurate Monte Carlo dose calculations
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1.9 Thesis Outline
1.9.1 Chapter 2: Implementation and commissioning of an integrated
micro-CT/RT system with computerized independent jaw collima-
tion
The design, construction and commissioning of an image-guided conformal small animal irra-
diator is documented in this chapter. Computer controlled motorized independent jaws were
designed, built, installed and commissioned for a commercial micro-CT scanner. The addition
of the jaws with other modifications converted the micro-CT into a micro-CT/RT system. The
design addressed the limitations of other pre-existing systems by allowing asymmetric fields
under computer control and gated delivery. This chapter is adapted from the research article,
“Implementation and commissioning of an integrated micro-CT/RT system with computerized
independent jaw collimation” published in Medical Physics, 2013, July 12;40(8): 081706 by
M. D. Jensen, W. T. Hrinivich, J. A. Jung, D. W. Holdworth, M. Drangova, J. Chen, and E.
Wong.
1.9.2 Chapter 3: Determination of effective atomic numbers and electron
densities with dual energy micro-CT measurements
Image-guided small animal irradiators employ kilovoltage photon beams (120 kVp to 320 kVp)
where the radiation dose is strongly dependent on the atomic number of the absorbing medium
due to photoelectric absorption. Dual energy CT (DECT) can measure the relative electron den-
sity (RED) and effective atomic number (EAN) independently and has been demonstrated with
clinical human CT scanners. We apply previously published DECT algorithms to micro-CT
images and experimentally investigate the feasibility of measuring the effective atomic num-
ber and relative electron density. A large number of test materials, including custom designed
phantoms, are examined with dual energy micro-CT for verification of results. While we found
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measurement of effective atomic number and relative electron density generally feasible, beam-
hardening artifacts were found to impact accuracy negatively. This chapter is adapted from the
research article, “Determination of effective atomic numbers and electron densities with dual
energy micro-CT measurements” by M. D. Jensen, J. Chen, and E. Wong.
1.9.3 Chapter 4: Improved determination of effective atomic numbers
and electron densities using dual energy micro-CT with optimized
spectra and a CMOS panel detector
The work of chapter 3 identified beam-hardening artefacts as a hindrance to accurate effec-
tive atomic number and relative electron density measurement with dual energy micro-CT.
Optimization of the x-ray spectra by additional filters narrows the spectral width and reduces
beam-hardening artefacts. The increased filtering also reduces the photon flux, requiring a
more sensitive detector to acquire images. We examine the improvement in measuring the
effective atomic number and relative electron density using harder spectra and a flat panel de-
tector. Additionally, four dual-energy CT processing methods are compared. This chapter is
adapted from the research article, “Improved determination of effective atomic numbers and
electron densities using dual energy micro-CT with optimized spectra and a CMOS panel de-
tector” by M. D. Jensen, S. Dawson, J. Chen, and E. Wong.
1.9.4 Chapter 5: Conclusions
In the final chapter, the conclusions of the prior chapters are summarized. Future work is
discussed. In summary, a small animal irradiator has been designed and constructed with a
more versatile collimation system and dual energy on-board CT scanning for image guidance.
Dual energy micro-CT was investigated for measuring phantom and in vivo tissue density
and atomic number for improving Monte Carlo dose calculation. This addresses some of the
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limitations of previously-available systems and will enable preclinical investigations into the
radiobiology of the biologically-guided radiotherapy of the future.
1.10 References
1D. Hanahan and R. A. Weinberg, “The hallmarks of cancer”, Cell 100, 57–70 (2000).
2D. Hanahan and R. A. Weinberg, “Hallmarks of cancer: the next generation”, Cell 144, 646–
674 (2011).
3Canadian Cancer Society’s Advisory Committee on Cancer, Canadian Cancer Statistics
2014, tech. rep. (Canadian Cancer Society, Toronto, ON, 2014).
4F. R. Eilber, “Principles of cancer surgery”, in Cancer treatment, edited by C. M. Haskell and
J. S. Berek, 5th ed. (W. B. Saunders Company, Philadelphia, PA, 2001) Chap. 5, pp. 47–52.
5R. G. Parker and H. R. Withers, “Principles of radiation oncology”, in Cancer treatment,
edited by C. M. Haskell and J. S. Berek, 5th ed. (W. B. Saunders Company, Philadelphia, PA,
2001) Chap. 5, pp. 52–62.
6C. M. Haskell, “Principles of cancer chemotherapy”, in Cancer treatment, edited by C. M.
Haskell and J. S. Berek, 5th ed. (W. B. Saunders Company, Philadelphia, PA, 2001) Chap. 5,
pp. 62–86.
7M. S. Mitchell, “Principles of biologic therapy”, in Cancer treatment, edited by C. M. Haskell
and J. S. Berek, 5th ed. (W. B. Saunders Company, Philadelphia, PA, 2001) Chap. 5, pp. 86–
103.
8T. Pham and L. Holle, Cancer therapy: prescribing and administration basics (Jones &
Bartlett Learning, Burlington, MA, 2015), p. 4.
9W. M. Mendenhall, A. A. Mancuso, R. J. Amdur, and J. W. Werning, “Laryngeal cancer”, in
Perez and Brady’s principles and practice of radiation oncology, edited by E. C. Halperin,
D. E. Wazer, C. A. Perez, and L. W. Brady, 6th ed. (Wolters Kluwer Health/Lippincott
Williams & Wilkins, Philadelphia, PA, 2013) Chap. 47, pp. 850–868.
10D. N. Kim, M. Story, and H. Choy, “Basic concepts of chemotherapy and irradiation inter-
action”, in Perez and Brady’s principles and practice of radiation oncology, edited by E. C.
Halperin, D. E. Wazer, C. A. Perez, and L. W. Brady, 6th ed. (Wolters Kluwer Health/Lippincott
Williams & Wilkins, Philadelphia, PA, 2013) Chap. 32, pp. 604–623.
11E. J. Hall and A. J. Giaccia, Radiobiology for the radiologist, 6th ed. (Wolters Kluwer
Health/Lippincott Williams & Wilkins, Philadelphia, PA, 2006).
12A. Ahnesjo¨, B. Hårdemark, U. Isacsson, and A. Montelius, “The IMRT information process–
mastering the degrees of freedom in external beam therapy”, Phys. Med. Biol. 51, R381–
R402 (2006).
13L. A. Dawson and M. B. Sharpe, “Image-guided radiotherapy: rationale, benefits, and limi-
tations”, Lancet Oncol. 7, 848–858 (2006).
Chapter 1. Introduction 23
14D. I. Thwaites and J. B. Tuohy, “Back to the future: the history and development of the
clinical linear accelerator”, Phys. Med. Biol. 51, R343–R362 (2006).
15D. Verellen, M. D. Ridder, and G. Storme, “A (short) history of image-guided radiotherapy”,
Radiother. Oncol. 86, 4–13 (2008).
16J.-Y. Jin, N. Wen, L. Ren, C. Glide-Hurst, and I. J. Chetty, “Advances in treatment tech-
niques”, Cancer J. 17, 166–176 (2011).
17K. T. Butterworth, K. M. Prise, and F. Verhaegen, “Small animal image-guided radiotherapy:
status, considerations and potential for translational impact”, Brit. J. Radiol. 88, 20140634
(2015).
18T. Bortfeld, “IMRT: a review and preview”, Phys. Med. Biol. 51, R363–79 (2006).
19T. R. Mackie, J. Kapatoes, K. Ruchala, W. Lu, C. Wu, G. Olivera, L. Forrest, W. Tome, J.
Welsh, R. Jeraj, P. Harari, P. Reckwerdt, B. Paliwal, M. Ritter, H. Keller, J. Fowler, and M.
Mehta, “Image guidance for precise conformal radiotherapy”, Int. J. Radiat. Oncol., Biol.,
Phys. 56, 89–105 (2003).
20W. Schlegel, “If you can’t see it, you can miss it: the role of biomedical imaging in radiation
oncology”, Radiat. Prot. Dosim. 139, 321–326 (2010).
21S. Webb, “Motion effects in (intensity modulated) radiation therapy: a review”, Phys. Med.
Biol. 51, R403–R425 (2006).
22J. Boda-Heggemann, F. Lohr, F. Wenz, M. Flentje, and M. Guckenberger, “kV cone-beam
CT-based IGRT: a clinical review”, Strahlenther. Onkol. 187, 284–91 (2011).
23K. Nakamura, T. Sasaki, S. Ohga, T. Yoshitake, K. Terashima, K. Asai, K. Matsumoto, Y.
Shioyama, and H. Honda, “Recent advances in radiation oncology: intensity-modulated ra-
diotherapy, a clinical perspective”, Int. J. Clin. Oncol. 19, 564–569 (2014).
24C. C. Ling, J. Humm, S. Larson, H. Amols, Z. Fuks, S. Leibel, and J. A. Koutcher, “Towards
multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality”,
Int. J. Radiat. Oncol., Biol., Phys. 47, 551–560 (2000).
25S. M. Bentzen and V. Gregoire, “Molecular imaging-based dose painting: a novel paradigm
for radiation therapy prescription”, Semin. Radiat. Oncol. 21, 101–110 (2011).
26T. Z. Vern and W. Small, Jr., “Targeted therapies: definitions, limitations, and future direc-
tions”, in Combining targeted biological agents with radiotherapy: current status and fu-
ture directions, edited by W. Small, Jr. (Demos Medical Publishing, New York, NY, 2008)
Chap. 1, pp. 1–15.
27E. R. Mardis and R. K. Wilson, “Cancer genome sequencing: a review”, Hum. Mol. Genet.
18, R163–R168 (2009).
28D. A. Torigian, S. S. Huang, M. Houseni, and A. Alavi, “Functional imaging of cancer with
emphasis on molecular techniques”, CA-Cancer J. Clin. 57, 206–224 (2007).
29G. A. M. S. van Dongen, A. J. Poot, and D. J. Vugts, “PET imaging with radiolabeled an-
tibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET”, Tumor Biol. 33, 607–
615 (2012).
Chapter 1. Introduction 24
30C. Peyssonnaux and A. Eyche`ne, “The Raf/MEK/ERK pathway: new concepts of activation”,
Biol. Cell 93, 53–62 (2001).
31H. Davies, G. R. Bignell, C. Cox, P. Stephens, S. Edkins, S. Clegg, J. Teague, H. Woffendin,
M. J. Garnett, W. Bottomley, N. Davis, E. Dicks, R. Ewing, Y. Floyd, K. Gray, S. Hall, R.
Hawes, J. Hughes, V. Kosmidou, A. Menzies, C. Mould, A. Parker, C. Stevens, S. Watt, S.
Hooper, R. Wilson, H. Jayatilake, B. A. Gusterson, C. Cooper, J. Shipley, D. Hargrave, K.
Pritchard-Jones, N. Maitland, G. Chenevix-Trench, G. J. Riggins, D. D. Bigner, G. Palmieri,
A. Cossu, A. Flanagan, A. Nicholson, J. W. C. Ho, S. Y. Leung, S. T. Yuen, B. L. Weber, H. F.
Seigler, T. L. Darrow, H. Paterson, R. Marais, C. J. Marshall, R. Wooster, M. R. Stratton, and
P. A. Futreal, “Mutations of the BRAF gene in human cancer”, Nature 417, 949–54 (2002).
32G. A. McArthur, P. B. Chapman, C. Robert, J. Larkin, J. B. Haanen, R. Dummer, A. Ribas,
D. Hogg, O. Hamid, P. A. Ascierto, C. Garbe, A. Testori, M. Maio, P. Lorigan, C. Lebbe´,
T. Jouary, D. Schadendorf, S. J. O’Day, J. M. Kirkwood, A. M. Eggermont, B. Dre´no, J. A.
Sosman, K. T. Flaherty, M. Yin, I. Caro, S. Cheng, K. Trunzer, and A. Hauschild, “Safety and
efficacy of vemurafenib in BRAF(V600E) and BRAF(V600K) mutation-positive melanoma
(BRIM-3): extended follow-up of a phase 3, randomised, open-label study”, Lancet Oncol.
15, 323–32 (2014).
33I. W. Y. Mak, N. Evaniew, and M. Ghert, “Lost in translation: animal models and clinical
trials in cancer treatment”, Am. J. Transl. Res. 6, 114–118 (2014).
34M. Ingrisch and S. Sourbron, “Tracer-kinetic modeling of dynamic contrast-enhanced MRI
and CT: a primer”, J. Pharmacokinet. Pharmacodyn. 40, 281–300 (2013).
35C. Marcus, V. Ladam-Marcus, C. Cucu, O. Bouche´, L. Lucas, and C. Hoeffel, “Imaging tech-
niques to evaluate the response to treatment in oncology: current standards and perspectives”,
Crit. Rev. Oncol. Hematol. 72, 217–238 (2009).
36F. Verhaegen, P. Granton, and E. Tryggestad, “Small animal radiotherapy research platforms”,
Phys. Med. Biol. 56, R55–R83 (2011).
37M. A. Khan, J. Van Dyk, I. W. T. Yeung, and R. P. Hill, “Partial volume rat lung irradiation;
assessment of early dna damage in different lung regions and effect of radical scavengers”,
Radiother. Oncol. 66, 95–102 (2003).
38N. S. Bese, C. Umay, S. Serdengecti, N. Kepil, N. Sut, T. Altug, and A. Ober, “The impact
of trastuzumab on radiation-induced pulmonary fibrosis: results of an experimental study”,
Med. Oncol. 27, 1415–9 (2010).
39Z. N. Rabbani, J. Mi, Y. Zhang, M. Delong, I. L. Jackson, K. Fleckenstein, F. K. Salahuddin,
X. Zhang, B. Clary, M. S. Anscher, and Z. Vujaskovic, “Hypoxia inducible factor 1α signal-
ing in fractionated radiation-induced lung injury: role of oxidative stress and tissue hypoxia”,
Radiat. Res. 173, 165–74 (2010).
40T. Eldh, F. Heinzelmann, a. Velalakan, W. Budach, C. Belka, and V. Jendrossek, “Radiation-
induced changes in breathing frequency and lung histology of C57BL/6J mice are time- and
dose-dependent”, Strahlenther. Onkol. 188, 274–81 (2012).
Chapter 1. Introduction 25
41J. Wong, E. Armour, P. Kazanzides, I. Iordachita, E. Tryggestad, H. Deng, M. Matinfar, C.
Kennedy, Z. Liu, T. Chan, O. Gray, F. Verhaegen, T. McNutt, E. Ford, and T. DeWeese,
“High-resolution, small animal radiation research platform with x-ray tomographic guidance
capabilities”, Int. J. Radiat. Oncol., Biol., Phys. 71, 1591–1599 (2008).
42M. Matinfar, E. Ford, I. Iordachita, J. Wong, and P. Kazanzides, “Image-guided small animal
radiation research platform: calibration of treatment beam alignment”, Phys. Med. Biol. 54,
891–905 (2009).
43R. Clarkson, P. Lindsay, S. Ansell, G. Wilson, S. Jelveh, R. Hill, and D. Jaffray, “Character-
ization of image quality and image-guidance performance of a preclinical microirradiator”,
Med. Phys. 38, 845–856 (2011).
44W. van Elmpt, L. McDermott, S. Nijsten, M. Wendling, P. Lambin, and B. Mijnheer, “A
literature review of electronic portal imaging for radiotherapy dosimetry”, Radiother. Oncol.
88, 289–309 (2008).
45P. V. Granton, M. Podesta, G. Landry, S. Nijsten, G. Bootsma, and F. Verhaegen, “A com-
bined dose calculation and verification method for a small animal precision irradiator based
on onboard imaging”, Med. Phys. 39, 4155–4166 (2012).
46P. V. Granton and F. Verhaegen, “On the use of an analytic source model for dose calcula-
tions in precision image-guided small animal radiotherapy”, Phys. Med. Biol. 58, 3377–3395
(2013).
47S. J. van Hoof, P. V. Granton, and F. Verhaegen, “Development and validation of a treatment
planning system for small animal radiotherapy: SmART-Plan”, Radiother. Oncol. 109, 361–
366 (2013).
48H. Zhou, M. Rodriguez, F. Van Den Haak, G. Nelson, R. Jogani, J. Xu, X. Zhu, Y. Xian, P.
Tran, D. Felsher, P. Keall, and E. Graves, “Development of a micro-computed tomography-
based image-guided conformal radiotherapy system for small animals”, Int. J. Radiat. Oncol.,
Biol., Phys. 78, 297–305 (2010).
49M. Rodriguez, H. Zhou, P. Keall, and E. Graves, “Commissioning of a novel microCT/RT
system for small animal conformal radiotherapy”, Phys. Med. Biol. 54, 3727–3740 (2009).
50E. Graves, H. Zhou, R. Chatterjee, P. Keall, S. Gambhir, C. Contag, and A. Boyer, “Design
and evaluation of a variable aperture collimator for conformal radiotherapy of small animals
using a microCT scanner”, Med. Phys. 34, 4359–4367 (2007).
51P. Keall, G. Mageras, J. Balter, R. Emery, K. Forster, S. Jiang, J. Kapatoes, D. Low, M.
Murphy, B. Murray, C. Ramsey, M. Van Herk, S. Vedam, J. Wong, and E. Yorke, “The
management of respiratory motion in radiation oncology report of AAPM Task Group 76”,
Med. Phys. 33, 3874–3900 (2006).
52J. H. Hubbell and S. M. Seltzer, Tables of X-Ray Mass Attenuation Coefficients and Mass
Energy-Absorption Coefficients from 1 keV to 20 MeV for Elements Z = 1 to 92 and 48
Additional Substances of Dosimetric Interest (Version 1.4), tech. rep. (National Institute of
Standards and Technology, Gaithersburg, MD, 2004).
53M. Bazalova and E. Graves, “The importance of tissue segmentation for dose calculations for
kilovoltage radiation therapy”, Med. Phys. 38, 3039–3049 (2011).
Chapter 1. Introduction 26
54D. W. O. Rogers, “Fifty years of monte carlo simulations for medical physics”, Phys. Med.
Biol. 51, R287–R301 (2006).
55R. A. Rutherford, B. R. Pullan, and I. Isherwood, “Measurement of effective atomic number
and electron density using an EMI scanner”, Neuroradiology 11, 15–21 (1976).
56B. J. Heismann, J. Leppert, and K. Stierstorfer, “Density and atomic number measurements
with spectral x-ray attenuation method”, J. Appl. Phys. 94, 2073 (2003).
Chapter 2
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2.1 Introduction
Technology development of preclinical irradiators has lagged compared to clinical systems in
regards to providing conformal intensity-modulated therapy with onboard image guidance. The
limitation to deliver sophisticated radiation treatments to small animals has hindered translating
radiobiological studies to the clinic.1 Several groups have worked to bring image-guided con-
formal radiation therapy technology to small animal laboratories. The first group of irradiators
have been designed and constructed specifically for image guided small animal therapy. These
systems include the SARRP from John Hopkins and Xstraal,2,3 and the X-RAD 225Cx from
Princess Margaret Hospital and Precision X-Ray.4 Several other groups have purchased these
27
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or other systems, and have published on their capabilities. The Maastricht group has developed
a dose verification technique for the X-RAD 225Cx,5 while the group at University of Texas
Southwestern Medical Center has characterized an X-RAD 320.6 Others have constructed ra-
dioisotope based systems, such as the Washington University group.7,8 The last approach has
been to modify a micro-CT scanner to enable irradiations, the primary example is the system
at Stanford.9–12
The Stanford system is based on a previous generation micro-CT (GE eXplore RS120) with
factory standard x-ray generator, using commercial imaging control software utilizing only the
small focal spot.12 A motorized variable-aperture collimator was added to define pseudocircular
profiles of arbitrary width between 0.1 and 6.0 cm.12 A two-dimensional translation stage was
added to the couch to position the target at isocenter for irradiation, limiting the system to
mouse radiotherapy.9
In this work, we report a different modification of micro-CT scanner for RT purposes. The
three major enhancements are a computerized asymmetric jaw collimator, integrated therapy
control software, and gated therapy. The computerized asymmetric jaw is the next level of
sophistication in small animal collimation. Most systems, such as the SARRP and X-RAD
225Cx, still use manual static cone collimators. The Stanford collimator is the only other
computerized collimator known to the authors. However, the Stanford collimator effectively
emulates an extensive set of circular cones, and is unable to form asymmetric fields. Asym-
metric jaws provide more flexibility, potentially allowing for more efficient treatment plans.
Software was acquired and developed to integrate the functionality of the CT scanner hard-
ware and collimator hardware, allowing automated synchronized treatment plan delivery.
This modified scanner is the only dedicated small animal IGRT platform known to the
authors that can perform gated radiation therapy.
Additional minor upgrades include upsizing to a larger x-ray generator and enhancements
to the shielding and cooling. The existing imaging capabilities of the system were retained. In
Chapter 2. Commissioning an integrated micro-CT/RT with jaw collimation 29
this paper, we will focus on the design and evaluation of the custom-built motorized orthogonal
jaws, and radiation therapy capabilities of the system, including gated delivery.
2.2 Materials and Methods
2.2.1 General design considerations
The desired end capabilities of the system are to irradiate small rodents, primarily mice and
rats. Initially, we expect most studies to be improvements over previous non-image guided
techniques which often have a larger irradiated volume. In place of irradiating half the animal,
we plan to irradiate an entire organ, or a large fraction of the (tumour bearing) organ, utiliz-
ing image guidance to reduce margins and ensure target coverage. For example, instead of
irradiating the entire rodent thorax, we would irradiate the lower right lung lobe localized by
fluoroscopic image guidance. With this in mind, we have focused most of our characterizations
on the field sizes ranging from 30 mm to 2 mm. Most systems move the target to isocenter and
employed a collimator. However, the design of the micro-CT with a 10 cm diameter bore ex-
cludes translating the couch laterally to place the flank tumour on a rat at the isocenter. With
this consideration, we designed and implemented a motorized jaw collimator to allow asym-
metric beams. Additionally, orthogonal jaws are familiar to the radiation oncology community.
With this design, we can utilize techniques such as dynamic wedge, or implement simple jaws
only IMRT for small animals in the future.13,14
The jaw collimator is mounted on the bore, closer to the subject, as opposed to at the tube
exit window. Several reasons lead us to this design decision. First, by being closer to the
subject, we reduce geometric penumbra. Second, by reducing the magnification factor, small
positioning errors in the jaws are not magnified to large errors. The reduction of magnification
allows us to build larger components with more generous mechanical error tolerances, which
reduces manufacturing and design time.
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2.2.2 Hardware
2.2.2.1 Micro-CT/RT
The base hardware of the image guided small animal irradiator system is a GE eXplore CT
120 (GE Healthcare, Milwaukee WI USA). We have upgraded to a 50 kW x-ray generator
(Indico 100, CPI Georgetown ON, Canada) that replaces the factory standard 32 kW generator
and enables the x-ray tube to be operated at 140 kVp. We use the factory standard x-ray tube
(PX1483, Dunlee, Aurora, IL, USA) with dual focal spot sizes of 0.3 mm and 1.0 mm. The
beam is filtered by the equivalent of 4.5 mm of aluminum. A sagittal laser was added to the
system to complement the factory standard axial and coronal lasers to allow for identification
of the treatment isocenter. The imaging capabilities of this scanner model were reported by
Bahri et al.15 using the vmCT phantom.16
2.2.2.2 Collimator
A CAD rendering and photos of the collimator are given in figure 2.1. The collimator was
designed to clamp onto the bore of the micro-CT. Supporting electronics and power supplies
were mounted on a custom plate, designed to attach to the micro-CT gantry using pre-existing
threaded holes.
The collimator consists of two jaw pairs. The x jaws move orthogonal to the CT axis of
rotation, and are independently controlled. The y jaws are symmetric, and move parallel to
the CT axis of rotation. The jaws are moved by three stepper motors (Wantai Motor Co. Ltd.,
Changzhou City, Jiangsu, China), two for the x jaws, and one for the y jaws. All jaw positions
are monitored with capacitive encoders (CUI Inc., Tualatin OR, USA). A limit switch at the
end of each jaw track is used to calibrate the jaw position at system startup. Motor control and
encoder readout is provided by control boards with USB interfaces (Phidgets Inc., Calgary AB,
Canada). A small single board computer running embedded Linux (Phidgets Inc.) is attached
to the USB interface boards and provides overall control and communication for the collimator.
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Figure 2.1: CAD rendering of the computer controlled collimator (a). Photo of the jaws
mounted on the Micro-CT bore (b). X1 jaw motor and position encoder are visible in lower
right of the figure. Y jaw rack and pinion motor drive is visible in upper right of the figure.
Photo of micro-CT gantry before collimator installation (c). The collimator mounts onto the
micro-CT bore, sitting above the detector assembly. The support electronics mount onto the
gantry.
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This single board computer is mounted on the gantry, and communicates to the console over
Ethernet.
All jaws consist of a polyoxymethylene base laminated with 1 mm of lead. The x jaws
translate by a lead screw mechanism. The y jaws are moved with a rack and pinion mechanism.
The frame structure was fabricated in aluminum and assembled by the department machine
shop.
2.2.3 Software
Collimator controller software was written in C, making use of the software libraries provided
with the USB interface boards (Phidgets Inc.). Collimator console software was written in
Java.
Third-party radiation therapy (RT) control software (Parallax Innovations, London ON,
Canada) was used in place of the factory supplied micro-CT control software. The custom
RT software controls all aspects of the system and allows defining treatment protocols and
accessing modes of operation of the micro-CT hardware that were not available in the factory
console software. For example, the RT software allows us to irradiate using the large focal
spot at 140 kVp, as opposed to the factory software that restricts exposures to the small focal
spot and 120 kVp. Additionally, an interface between the RT software and collimator software
allows for automated delivery of conformal and simple step-and-shoot plans.
2.2.4 System calibration and performance characterization
We first verified the system’s isocenter by placing a small ball bearing (BB) on the couch and
images were acquired from multiple directions. The images of the BB were compared to the
results of the CT image reconstruction calibration. The BB position was iteratively adjusted
until the BB images agreed with the reconstruction parameters. The lasers were then adjusted
such that they intersected at the corrected BB position.
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2.2.4.1 Jaw position calibration and accuracy assessment
Each of the collimator jaws were stepped across the full beam width in increments of ap-
proximately 1 cm. Fluoroscopy images were acquired of the shadows cast by the jaws at each
position. Line profiles were then taken perpendicular to the jaw edge in the fluoroscopy images,
and the position of the half maximum intensity was determined. A jaw position lookup table
was then compiled using the stepper motor counts and the half maximum intensity positions,
and implemented in the software.
Three aspects of the jaw performance were accessed: jaw homing reproducibility, motor
control accuracy, and mechanical play and backlash. Jaw homing occurs when the system
starts up and moves the jaws to the end of the motion track and trips a mechanical switch to
set the home or zero position. To access jaw homing reproducibility, the jaws were homed,
subsequently moved to 2 cm from isocenter, and a fluoroscopy image was acquired. This was
repeated at 5 gantry positions (0°, 45°, 90°, 180°, 270°) with a total repetition of 54 times, and
the standard error of each jaw edge was computed.
For this work, motor control accuracy is defined as the ability of the control software and
electronics to rotate the stepper motors the correct number of steps. To assess motor control
accuracy, 60 random jaw configurations were selected such that no consecutive jaw configura-
tions were the same (exclude all changes where there would be no jaw movements). The jaws
were then moved to each of the random jaw positions and the encoder position was recorded.
Recall that the encoders are used for independent verification of position, and are not used as
feedback to the motor control.
Mechanical play and backlash is the error attributed to the play or slop in the gears and
lead screws. Backlash is a consistent error that occurs when the system changes direction.
Mechanical play and backlash in the x jaw mechanisms were accessed by stepping the jaws to
three consecutive positions, and then reversing direction and stepping to the previous positions.
For example, the x1 jaw was moved in the order from 30 mm to 20 mm, 10 mm, 20 mm, and
back to 30 mm. The jaw edge position was determined using fluoroscopic imaging as described
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above and repeated four times. Mechanical play and backlash in the y jaws were accessed with
the same procedure.
We recognize the limitation of these tests in separating the three effects. However, each test
gives a reasonable estimation of the desired effect while minimizing the influence of the other
effects.
All jaw position and speed measurements were scaled to be at isocenter for reporting.
2.2.5 Dosimetry
2.2.5.1 Measurements
2.2.5.1.1 Exposure settings All measurements were completed at 140 kV, 50 mA and
25 ms pulse duration, with 220 ms between pulses using the large focal spot, unless other-
wise stated.
2.2.5.1.2 Jaw Transmission The jaws were closed, and the transmission measured with
the Farmer type ion chamber.
2.2.5.1.3 Output Beam output was measured using a 0.6 cm3 Farmer chamber (type 30013,
PTW, Freiburg Germany) inside a 70 × 70 × 20 mm3 solid water block. This chamber was cross
compared to the local standards at beam energies ranging from 80 kV to 18 MV, and found to
be in agreement. Symmetric square fields of 60 × 60, 50 × 50, 40 × 40 and 30 × 30 cm2 were
centered on the active volume of the ion chamber, and irradiated with 500 pulses.
2.2.5.1.4 Radiochromic film processing Radiochromic film (EBT2, Ashland Inc., Cov-
ington KY, USA) was digitized at 72 dpi using a transmission mode flatbed scanner (Expres-
sion 10000XL, Seiko Epson Corp., Suwa, Nagano, Japan). Film processing was based on work
by Devic et al.17,18 and McCaw et al.,19 and is described in detail in appendix A. The film was
calibrated for the range of 0 to 8 Gy by comparison with ion chamber measurements.
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2.2.5.1.5 Absolute depth dose Absolute depth dose was measured using a cubic solid wa-
ter and radiochromic film phantom with dimensions of 50 × 50 × 50 mm3. The films were
scanned and converted to dose. Symmetric fields of sizes 40 × 40 and 20 × 20 mm2 were
examined with 24 films perpendicular to the beam axis, separated by 2 mm of solid water.
Similarly, a 2 × 2 mm2 field was characterized with 12 films placed every 4 mm at different
depths.
2.2.5.1.6 Beam profiles (FWHM, symmetry, flatness, penumbra) Beam profiles of sym-
metric fields of sizes 60 × 60, 50 × 50, 40 × 40, 30 × 30, 20 × 20, 10 × 10, 5 × 5 and 2 × 2 mm2
were also examined using EBT2 radiochromic film at isocentre, at a depth of 2 and 12 mm in a
solid water phantom. Only the films at a depth of 12 mm are presented. The FWHM was calcu-
lated as the width of the beam at 50% the maximum intensity. Beam symmetry was quantified
based on the left-side and right-side dose of the beam profile at 80% of the FWHM using
S = max
(
100 × Dleft − Dright
Dleft + Dright
)
. (2.1)
Flatness was computed by finding the maximum and minimum dose in the middle 80% extent
of the beam profile and applying
F = 100 × Dmax − Dmin
Dmax + Dmin
. (2.2)
Penumbra was calculated by computing the distance between the points of 20% and 80% max-
imum dose.
2.2.5.1.7 Beam profile with asymmetric field A 30 × 30 mm field, off-axis by 10 mm was
delivered to a film at isocentre at a depth of 12 mm in solid water. Two 10 × 10 mm fields,
off-axis by 15 and 25 mm were also delivered to film at isocentre.
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2.2.5.2 Monte Carlo modeling
We used the Monte Carlo package EGSnrc.20,21 A Monte Carlo beam model of the system was
built in BEAMnrc,22 with dose calculations performed in DOSXYZnrc.23 We used the work by
Bazalova et al.11 to develop the model. The XTUBE component module was configured to the
manufacturer’s published specifications of the x-ray tube (anode angle, material composition,
geometry). The electron source is modelled as a parallel circular beam of radius 0.5 mm for
the large focal spot to approximate the effective spot size of 1 mm. The simulation output was
calibrated against the ion chamber output measurements. The model was verified by comparing
the beam profiles of the simulations to the film measurements for symmetric fields of sizes 60
× 60, 50 × 50, 40 × 40, 30 × 30, 20 × 20, 10 × 10, 5 × 5 and 2 × 2 mm2 and asymmetric fields
of sizes 10 × 10 mm2 and 30 × 30 mm2. Modeled absolute depth dose curves were compared
to measured ones for the following field sizes: 40 × 40, 20 × 20, and 2 × 2 mm2.
Monte Carlo simulations were run with sufficient histories such that in the high dose re-
gions, the reported uncertainty was 3% or less.
2.2.5.3 Focal spot size
One difference between the Stanford system and this system is the use of the large focal spot.
Two films were exposed with 2 × 2 mm2 fields, the first using the small focal spot, and the
second using the large focal spot. The two fields with different focal spot sizes were also
modelled with Monte Carlo.
2.2.6 Elliptical target
Two simple 3D conformal plans to irradiate a 20 mm × 10 mm elliptical cylinder target were
used to qualitatively access overall machine performance. One plan consisted of 9 beam di-
rections, and the second 31 beam directions. Film was sandwiched vertically in a solid water
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cube with side lengths of 50 mm. The films were examined for asymmetry that would indicate
gantry sag, or collimator malfunctions.
2.2.7 Image guidance
A simple phantom was constructed with three non-metallic 2.3 mm BBs (CT-SPOT, Beekley
Medical, Bristol, CT, USA) inside the interior of a cubic polystyrene phantom. The phantom
could be split to insert a radiochromic film. One BB, not at isocenter, was localized by CT
imaging. A plan to irradiate the BB was manually generated with four asymmetric beams of
5 × 5 mm2 centered on the BB. The phantom was removed and replaced onto the couch and
repositioned using fluoroscopy guidance. The phantom with film was then irradiated with the
four beam plan. The targeting accuracy was verified by examination of the radiochromic film
and comparing the centroid of the BB and the high dose region. This was repeated 6 times to
access repositioning accuracy.
2.2.8 Respiratory gating
We have performed a number of pilot gated rat lung irradiations in collaboration with a MR
imaging group (G. Santyr) at our institution. All procedures followed animal care protocols
approved by the University of Western Ontario (ACVS) and were consistent with procedures
used by the Canadian Council on Animal Care (CCAC).
From a cohort of 12 200–250 g Sprague-Dawley rats, we estimated the diaphragm motion
to be approximately 5 mm at a breath rate of 50–60 breaths per minute free breathing under 1–
2% isoflurane. One technique to compensate for motion is to gate the delivery. This system is
capable of performing gated imaging with the addition of a small animal physiology monitoring
system. We adapt the gated imaging scanner hardware for gated radiation therapy. While the
diagnostic imaging x-ray system is disadvantageous for producing a high dose rate compared
to therapy tubes, one advantage is the fine control over the x-ray exposure timing. Normally
the system is operated with a 10% duty cycle to balance heat accumulation and continuous x-
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ray pulsing. For a gated delivery, the x-ray exposure is triggered to occur during the breathing
window with an extended duration to maintain a 10% duty cycle. The duration of the therapy
exposure is adjusted to match the breathing rate of the animal and maintain close to a 10% duty
cycle. Hence, we managed to deliver gated treatments in the same amount of time as normal
un-gated treatments. A sample of the respiratory trace and gating window from the animal
monitoring system is shown in figure 2.2. Also shown are the duration and timing of x-ray
exposures for a non-gated and gated irradiation.
A prototype small animal respiratory motion phantom was constructed, with variable period
control (figure 2.3). The phantom moves a platform in a sinusoidal motion with a frequency of
0.83 Hz (imitating an anesthetized rat breath rate of 50 breaths per minute), with a peak to peak
amplitude of 5 mm. The phantom provides a gating signal by squeezing the same respiratory
pillow used with small animals. The small animal monitoring system (SA Instruments, Inc.
Stony Brook NY, USA) generated a gating window from the respiratory signal. The gating
output of the small animal monitoring system was connected to the built-in gating hardware
of the micro-CT scanner. With the custom RT software, the x-ray exposure is triggered at the
start of the gating window for an irradiation type delivery. The pulse duration was changed
from 25 ms to 125 ms to match the breath rate. A radiochromic film was placed on the motion
platform and a dose of 2 Gy to a field size of 20 × 20 mm2 was delivered with respiratory
gating. A second film was exposed with no gating, and a third with no motion.
A rat’s thorax was scanned using the micro-CT (70 kVp, 32 mA) first without gating,
and then with respiratory gating. Since the same systems of microCT hardware and animal
monitoring are used to gate the image acquisition and to gate therapy, the quality of the gated
image is a surrogate to the quality of the gated delivery in an animal.
2.2.8.1 Example animal IGRT
A cohort of Sprague-Dawley rats were irradiated to 18 Gy in their right lung. Equally weighted
parallel opposed oblique beams were employed to spare the left lung and heart. The fields were
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Figure 2.2: Sample of the respiratory waveform and gating window produced by the small
animal monitoring system. Inspiration coincides with the valleys in the waveform. Shown at
the top is the ungated x-ray exposure protocol of 25 ms pulses separated by 220 ms. For a
gated delivery the exposure is triggered by the beginning of the gated window. The exposure
duration is chosen to achieve close to a 10 percent duty cycle. For this figure, the respiration
period is approximately 1080 ms, with an exposure duration of 125 ms.
Figure 2.3: Motion phantom used to test respiratory gating functionality. A speed adjustable
rotating cam causes a platform to move sinusoidally, with a solid water block and radiochromic
film. Simultaneously, an elastic band is stretched, compressing the small animal respiratory
pillow creating the gating signal for the micro-CT scanner.
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placed using fluoroscopic guidance, ensuring the heart, spine and diaphragm were shielded.
An optimal gantry angle is first chosen using fluoroscopic imaging to spare the heart and spine.
The jaws are then positioned to shield the heart, spine and diaphragm. The gantry and jaw
parameters and pre-treatment CT images from the treatment were used to perform a Monte
Carlo dose verification calculation. The dose calculation was performed as described above,
using the 8-tissue segmentation technique.24
2.3 Results
2.3.1 Collimator performance
Jaw measurements are reported at isocenter. The x jaws move with a speed of 7.7 mm/s,
while the y jaws move with a speed of 10 mm/s. Jaw transmission was measured to be 1%.
Jaw homing repeatability was quantified to have a standard deviation of 0.07 mm in the X jaws,
and 0.3 mm in the Y jaws. Repeated random jaw movements showed the average absolute error
between the desired jaw position and the encoder position was (3.5 ± 0.4)×10−5 mm in the x
jaws, and (3.1 ± 0.4)×10−2 mm in the y jaws. A consistent backlash effect is dwarfed by the
random error of the jaws. For the mechanical play x jaws test, the mean error was 0.0004 mm,
with a standard deviation of 0.003 mm. The y jaws backlash mean error was 0.02 mm, with
a standard deviation of 0.08 mm. One explanation is the vibrations of the collimator during
operation results in the jaws coming to rest in a random position within the mechanical play
envelope, and not consistently resting against the gear face transmitting the force.
The variability in homing the jaws at start-up is the largest source of error, being an order
of magnitude larger than the error of the play in the mechanical linkages, and several orders
larger than the error in the motor control.
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Figure 2.4: Relative output factors for field sizes ranging from 2 × 2 to 60 × 60 mm2 as
measured with EBT2 film (+) and ion chamber (o), and calculated by Monte Carlo (–×–) (a).
All measurements were normalized to the 50 × 50 mm2 field. Error bars for the film are shown.
Absolute depth dose in solid water, EBT2 Film and Monte Carlo, for square fields of size 2, 20
and 40 mm2 (b). Film dose is shown as solid lines with error bars; Monte Carlo dose is shown
as dashed lines.
2.3.2 Dosimetry
2.3.2.1 Output
For the reference 50 × 50 mm2 field, at isocenter and at a depth of 10 mm in solid water, the
dose per current-time product (mAs) was measured to be (9.53 ± 0.02)×10−4 Gy/mAs. With
the heating limitations of the system (10% duty cycle), this works out to an average dose rate
of approximately 0.3 Gy/min.
A comparison of relative output factors from ion chamber measurements, film measure-
ments and Monte Carlo simulations is shown in figure 2.4a. Ion chamber measurements and
Monte Carlo differ by less than 2%. This very small discrepancy in ion chamber measurement
with Monte Carlo could be explained by partial volume effects. All but two of the films agree
within the film error of 3.6% with Monte Carlo. The larger discrepancies are the 2 × 2 and 20
× 20 mm2 fields, with differences of 5.7% and 4.6%.
Chapter 2. Commissioning an integrated micro-CT/RT with jaw collimation 42
2.3.2.2 Absolute depth dose
Comparisons of radiochromic film measurements with the Monte Carlo simulations are shown
in figure 2.4b. There is good agreement between film and simulation for the larger 40 × 40 and
20 × 20 mm2 fields, with all points falling with the film uncertainty of 3.6% of the dose nearest
the surface. The 2 × 2 mm2 field shows a consistent 3% disagreement at depths below 24 mm.
Nine of twelve film measurements include the Monte Carlo value within the uncertainty of
3.6%, with the largest difference at 5%.
Compared to the Stanford system with an approximate dose decrease of 10% for every
5 mm of depth,12 this system has an approximate dose decrease of 7.5% with every 5 mm of
depth. This result is concurrent with the higher beam energy, and increased beam filtration of
4.5 mmAl compared to 2.5 mmAl.24,25
2.3.2.3 Beam profiles
Sample of beam profiles at 12 mm depth are shown in figure 2.5, and the measured parameters,
such as FWHM, are presented in table 2.1. The x-ray tube anode heel effect is evident in the
superior-inferior beam profiles of the large fields (figure 2.5b). The heel affect is also measured
by the deteriorating symmetry and flatness, and the widening penumbra, in the superior-inferior
direction compared to the left-right direction in the large 40 × 40, 50 × 50 and 60 × 60 mm2
fields as shown in table 2.1. There is no flattening filter in the beam, so this result was expected.
The simulations and film agree within the film uncertainty of 3.6% of the maximum dose.
On the larger fields, there is some discrepancy in the dose of the tails (figures 2.5a and 2.5b),
which is not present for the smaller fields (figures 2.5c and 2.5d). The film shows higher dose
than the Monte Carlo simulations in these penumbra tails. One explanation is backscattered
photons from the detector, as the detector is not modelled in the simulations.
To compare beam characteristics with the Stanford system, we examine the field sizes of 5
× 5, 10 × 10 and 20 × 20 mm2 against the pseudo-circular beams of radius 5, 10 and 20 mm.
The penumbra of approximately 0.5, 0.6 and 0.7 mm is not far off the values reported by
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Field Size (mm × mm)
2 × 2 5 × 5 10 × 10 20 × 20 30 × 30 40 × 40 50 × 50 60 × 60
FWHM Left-right 2.05 4.98 10.39 20.31 29.81 40.27 49.77 59.54
(mm) Sup-inf 1.96 5.02 10.00 19.87 29.26 39.56 49.46 59.38
Flatness Left-right 13.82 4.14 2.44 4.22 4.15 5.30 4.03 5.94
(%) Sup-inf 15.72 4.40 3.08 3.77 3.05 6.24 7.72 8.75
Symmetry Left-right 5.22 1.35 0.42 1.20 1.49 2.32 0.67 1.61
(%) Sup-inf 7.04 1.93 0.53 0.72 0.75 1.96 5.15 3.40
Penumbra Left-right 0.39 0.54 0.61 0.69 0.75 0.97 0.94 1.30
(mm) Sup-inf 0.46 0.48 0.57 0.73 0.78 0.97 1.31 2.37
Table 2.1: Beam profile characteristics from EBT2 film measurements at isocenter and 12 mm
depth
Rodriguez et al.12 of 0.45, 0.45 and 0.6 mm. The beam flatness is also similar, with values
ranging from 2.4% to 4.4% for this system, compared to 3.4% to 3.7% for the Stanford system.
Symmetry is slightly worse for this system, ranging from 0.42% to 1.93% compared to 0.1%
to 1.0% for the Stanford system.
Comparison is not straight forward, as the square fields are larger in area than the corre-
sponding pseudo-circular beams resulting in different photon scatter potential. As well, the
measurements are taken at 10 mm versus 1 mm depth.
Another consideration is the appropriateness of these metrics for such small beams. For
the 2 × 2 mm2 field, the flatness metric is very high, 13% to 15%. At this size, the beam won’t
have a flat region and the flatness measurement is not informative. Similarly, the symmetry
metric is also not useful for this small field. As the field gets smaller, the 80% of the maximum
dose will fall on a steep gradient, and will cause the symmetry metric to be overly sensitive.
Overall, these results suggest this system has beam characteristics that are suitable for
irradiating small animals, and are similar to the existing Stanford system in use.
2.3.2.4 Asymmetric field beam profile
Figures 2.5e and 2.5f show the 10 × 10 mm2 field off-axis by 25 mm. The film and simulation
agree within the film uncertainty of 3.6% of the maximum dose.
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Figure 2.5: Beam profiles at 12 mm depth in a 70 × 70 × 22 mm3 solid water block. Film
profiles have been normalized to ion chamber scaled Monte Carlo. Left-Right (a) and Superior-
Inferior (b) profiles of a 40 × 40 mm2 field. Left-Right (c) and Superior-Inferior (d) profiles
of a 5 × 5 mm2 field. Left-Right (e) and Superior-Inferior (f) profiles of a 10 × 10 mm2 field,
offset from the central axis by 25 mm. Solid lines are film measurements, dashed lines are
Monte Carlo.
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2.3.2.5 Focal spot size
Results from film measurements and simulations show the differences between the small and
large focal spot are within error. Calculations of geometric penumbra for this system are 0.054
and 0.072 mm for x and y jaws for the small focal spot, and 0.18 and 0.24 mm for the large
focal spot. These are smaller than the film sampling interval (0.35 mm) and simulation voxel
size (0.25 mm). With the collimator mounted closer to the subject, geometric penumbra is
minimized, reducing the effect of focal spot size. However, going to the large focal spot for the
2 × 2 mm2 field allows for an increase in mA resulting in close to a doubling of the dose rate.
2.3.3 Elliptical target
Elliptical target films are presented in figure 2.6. Qualitatively, the dose distributions look sym-
metric, indicating good collimator and system performance. No gantry sagging or other overt
errors are detected. The high dose region appears uniform. The jaws are able to successfully
conform to an elliptical cylindrical target.
2.3.4 Image guidance
One film from the 6 image guidance targeting experiments is shown in figure 2.7. For the five
remove-and-replace BB phantom trials, the mean displacement between the BB centroid and
the high dose centroid is 0.6 mm, with a standard deviation of 0.1 mm. The maximum and
minimum displacements were 0.7 and 0.4 mm.
2.3.5 Gating
The dose distribution to a moving film without gating has a penumbra of 3.9 mm in the motion
direction. The gated film has a penumbra of 0.8 mm, and no motion film a penumbra of 0.5 mm.
The gated and ungated films are shown in figure 2.8. The reduction of the penumbra in the
direction of motion by approximately 80% is quite substantial. The phantom moves in a simple
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Figure 2.6: Irradiation of an elliptical target (major axis 20 mm, minor axis 10 mm.), measured
on EBT2 film. Dose distribution of nine field plan (a) and thirty-one field plan (b). Scale bar is
5 mm. Perpendicular dose profiles through the center of the dose distribution for the nine field
plan (c) and the thirty-one field plan (d). Solid lines are the horizontal profiles; dashed lines
are the vertical profiles.
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Figure 2.7: Image guided irradiation of off-axis BB with 5 × 5 mm2 fields from four directions.
Three 2.3 mm diameter BBs are visible. The bottom left BB was targeted for irradiation.
Relative dose contours. Scale bar is 5 mm. The four beams with parameters are: (Gantry,
X1 mm, X2 mm) (0°,−2.5,−7.5), (45°,−3.0,−8.0), (90°,−0.5,−5.5), (135°,4.0,−1.0).
1D sinusoidal motion, which is not a good representation of a small animal. Tissue deformation
and the non-equal time spent in the inspiration and expiration phases are not modeled by the
motion phantom. However, the phantom test successfully demonstrates the basic functionality
of the gating systems.
Figure 2.9 compares an ungated and gated CT image acquisition on the same rat. Respi-
ratory gating reduced the motion artifacts in the image. By the fact that both the imaging and
therapy gating are performed by the same hardware, we argue the gated therapy will reduce the
therapy beam blurring, as the gated imaging reduces the image blur. However, it’s difficult to
quantify the amount of the reduction in motion artifact in the dose deposited into lungs due to
the deformation.
2.3.6 Example animal IGRT
Figures 2.10a and 2.10b show the fluoroscopy image guidance used to place the lung fields.
An optimal gantry angle was chosen, as shown in figure 2.10a. The jaws are then set as shown
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Figure 2.8: Ungated (a) and gated (b) irradiation of an EBT2 film on a motion platform. Peak
to peak motion of 5 mm.
in figure 2.10b. The Monte Carlo dose verification is shown in figures 2.10c–2.10e. The bone
dose is approximately double the prescribed lung dose, due to the photoelectric absorption of
the bone at this low beam energy.
2.4 Discussion
Jaw homing variability is the primary source of jaw error, as it is an order of magnitude larger
than the other sources of error. With respect to the ideal targeting accuracy of ±0.1 mm for
mice, as proposed by Verhaegen et al.,1 the performance of the x jaw with a standard deviation
of 0.07 mm is comparable. The performance of the y jaw is disappointing, with a standard
deviation of 0.3 mm, which exceeds this ideal accuracy. However, at the current level of
sophistication in our lab, these error characteristics are acceptable, as we estimate errors in
animal positioning and target identification to be on the order of 1–5 mm.
Future revisions of the collimator design would replace the rack and pinion y jaw mech-
anism with a lead screw. For the current rack and pinion design, some of the error can be
detected as missed steps of the motor by the encoder. The software could be modified to use
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Figure 2.9: Micro-CT images of an anesthetized rat. Transverse ungated (a) and gated (b)
slices showing the lungs and heart. Sagittal ungated (c) and gated (d) slices through the left
lung. Note the motion blur artifacts on the diaphragm boundary and lung sub-structure are
reduced by gated image acquisition. However, cardiac motion blur is still evident, as the acqui-
sition was only respiratory gated. The same hardware systems and techniques used to perform
the gated image acquisition are used to deliver a gated therapy.
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Figure 2.10: Image guidance of AP irradiation field. Fluoroscopy images without (a) and with
(b) collimator in treatment position. Field was adjusted with image guidance to shield heart and
diaphragm. Monte Carlo dose verification for AP-PA parallel opposed beam plan; transverse
(c), sagittal (d) and coronal (e) slices shown. Scale bar is 10 mm.
encoder feedback to improve the y jaw position. Additionally, more reproducible homing de-
tection methods, such as improved mechanical switches or optical detectors would reduce the
jaw homing variability. Another approach to improve the jaw homing would be to image the
jaw positions with fluoroscopy after start-up and calculate a homing correction to be used for
that session. We have not currently implemented these features because the current error char-
acteristics are sufficient for our partial organ irradiations in rats. As we start moving towards
more precise irradiation experiments, we should be able to improve the system with software
changes.
Generally, the Monte Carlo simulations agree with the film within the measurement uncer-
tainty of 3.6%. The only consistent (3%) discrepancy is for the depth dose of the smallest field,
2 × 2 mm2. We are unsure if this consistent discrepancy is a measurement error, or a modeling
error, as the film dosimetry is very challenging for such a small field.
One limitation to the system is the dose rate. Nonetheless, the achieved dose rate of
0.3 Gy/min (10 mm depth, at isocenter, 140 kVp) is comparable, but slightly higher than the
dose rate reported by the Stanford group of approximately 0.2 Gy/min (surface, at isocenter,
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120 kVp).12 In comparison, the SARRP dose rate is approximately 10 times higher for a sim-
ilarly sized field.2 On our system, a typical 10 Gy treatment requires about 60 minutes for
treatment delivery, including cooling time for the x-ray tube. While not ideal for high through-
put studies, this is tolerable by small animals under isoflurane.
Small fields are practically undesirable on this system, as the dose rate penalty further
exacerbates the inherently low dose rate of the micro-CT. Geometric penumbra and focal spot
size ultimately affect the smallest field size available. For this system, the collimator is placed
far from the source, minimizing the penumbra. Even so, the geometric penumbra with the large
focal spot is 0.25 mm in the superior-inferior direction, limiting the smallest field available.
Going to the smaller focal spot reduces the geometric penumbra to 0.07 mm at the cost of
a further reduction in dose rate. We are also unlikely to use a field this small for our initial
experiments, as other sources of uncertainty would prevent the use of this field.
A lesion with diameter smaller than 5 mm would be very difficult to visualize with CT,
and would require fusing the CT to another imaging modality, such as MR. This would require
development of an immobilization device that would be CT, RT and MR compatible or a robust
deformable registration algorithm validated in small animals.
The manual aspect of the vertical couch adjustment and the lack of lateral couch adjustment
impede replicating animal setup. This was the major contributor of targeting error in the phan-
tom tests, as we could identify a misalignment with the fluoroscopic imaging, but could not
move the phantom precisely. To be able to confidently use the smaller beam sizes will require
more development work on animal positioning.
Additionally, the constrained size of the imaging bore restricts activities for commissioning
the system and placing animals for therapy with the associated supports for long anaesthetic
times.
Given the low 140 kV beam energy, Monte Carlo simulations will be needed to calculate
accurate dose, especially to bone, precluding the simple dose calculations.24,26,27 Therefore, the
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lack of flatness and symmetry in the beams is not a problem, as they can be accounted for
properly by Monte Carlo simulations.
The low beam energy also presents a potential problem with enhanced bone dose due to
the photoelectric effect. At this energy, bone within the field will receive approximately 50%
more dose compared to a higher energy beam available on other systems. The effect on the
hematopoietic system needs to be considered when planning therapy. If the volume of irradi-
ated red marrow is small relative to total red marrow, the effect will likely be negligible. To
quantify the volume of bone irradiated, we provided two examples in figure 2.11 of rat irra-
diations on our system where we generated and assessed the dose-volume histogram for the
bone with a prescription dose of 20 Gy. In either case, we estimated from a micro-CT scan of
the rat that less than 3% of total body bone volume was irradiated to 5 Gy. In addition, Lee
et al. reported a threshold for leukocytopenia of approximately 27% of red marrow irradiated
in a metastatic patient population on helical tomotherapy.28 While clinically known thresholds
are difficult to translate to animal studies, they provide a rough guideline. Since bone marrow
toxicities are disease model and site specific, we recommend that treatment planning be done
and bone dose-volume histograms be examined as in figure 2.11, in addition to other critical
organs.
Simple multi-beam irradiations and image guidance tests qualitatively demonstrated overall
performance of the system. Irradiating the elliptical target with a conformal plan is efficient
with the system, as collimator size can change automatically as the gantry rotates to the next
beam. Systems utilizing cones would require a cone change for each angle to achieve similar
conformality, or a raster scanning of a small cone. Asymmetric fields are a strong benefit of
this collimation system, enabling the irradiation of off-axis targets. The elliptical cylinder is
ideally suited to this jaw configuration. Many complex targets could be decomposed into a
series of elliptical cylinders, allowing this system to achieve conformal treatments for complex
shapes. However, decomposing into more than a few cylinders could make the delivery time
infeasible. Conformality comes at the expense of increased treatment time, like all the other
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Figure 2.11: An axial slice (a) of a 14 × 14 mm2 parallel opposed fields irradiating the right
lung to a total dose of 20 Gy delivered in 2 fractions. The bones in the scan field of view (the
thorax) were segmented (b). Approximately 10% of the bone is receiving a dose above 5 Gy as
shown in the dose volume histogram (e). The bone V5Gy is 0.25 cm3, which is approximately
2% of the total body bone volume of 14 cm3 including the tail, estimated from a total body
micro-CT scan. An axial slice (c) of a 10 × 10 mm2 lateral parallel opposed fields irradiating
a brain tumour to a total dose of 20 Gy delivered in 2 fractions. The skull was segmented (d).
Approximately 10% of the skull is receiving a dose above 5 Gy (e). The bone V5Gy is 0.4 cm3,
which is approximately 3% of the total body bone volume.
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existing systems. The development of a multi-leaf collimator for small animal IGRT could
greatly improve the treatment efficiency of complex targets.
Gating functionality is unique to this system, and these results show promise. More work is
required to further characterize the gating performance, specifically in animals. One approach
would be to develop a more advanced respiratory phantom that could play back a recorded an-
imal respiratory waveform. To test in animals directly, staining for DNA double-strand breaks
immediately after irradiation (γ-H2AX) may be sensitive enough to detect the field edges of
irradiation. Histology acquired at later time points, at inflammation or fibrotic stages may not
be ideal, as the damaged region could spread beyond the irradiated volume.
Overall, none of the existing small animal IGRT platforms currently have the ideal mix of
technology to replicate the sophistication of the clinic. The SARRP and XRAD-225Cx lack
computerized collimators, limiting the efficiency of conformal treatment. Intensity modulated
plans on these systems may require manual collimator changes during treatment and/or require
raster scanning of small cones. However, these purpose built devices offer some advantages,
including a high dose rate. The micro-CT based systems have more sophisticated collimators,
but suffer from a lower dose rate. The Stanford system has a motorized stage for precise
placement and is restricted to mice. The system described in this work employs the standard
micro-CT couch with a computerized asymmetric collimation to allow rats as well as mice in
a micro-CT geometry. In addition, gated radiation delivery is possible. These strengths fit the
niche of the rat oriented imaging studies common at our institution.
2.5 Conclusion
A computerized jaw based collimator has been designed, built and installed in a micro-CT. A
Monte Carlo dose package was configured to calculate the dose to small animals and validated
against film measurements. Work is still needed to develop a planning system, as currently
planning is done manually. The dose rate of the system is low compared to other irradiators,
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but has the advantages of being able to perform gated delivery and asymmetric fields, suitable
for both rats and mice. This system also offers the advantage that it is based on modifications to
an existing commercial design for micro-CT, taking advantage of the gantry, tube, and control
infrastructure that is already present, and retaining the existing capability for co-registered 3D
micro-CT imaging. We have characterized and commissioned the micro-CT hardware, and
the performance is satisfactory to perform the first cohort of image guided, conformal, small
animal irradiations studies.
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Chapter 3
Determination of effective atomic
numbers and electron densities with dual
energy micro-CT measurements
This chapter was adapted from the research article “Determination of effective atomic numbers
and electron densities with dual energy micro-CT measurements” by M. D. Jensen, J. Chen
and E. Wong.
3.1 Introduction
Preclinical radiobiology studies are required to investigate novel radiation and combination
therapies in animal models of cancer. To perform these experiments, a number of hardware
platforms to perform image-guided conformal small animal irradiations have been built. These
small animal image-guided radiation therapy (IGRT) systems bring the technical sophistication
of accurate and precision irradiation from the clinical environment to the preclinical laboratory.
However, preclinical radiobiology data collected from studies with large dosimetric uncertain-
ties will be of limited value.
Most small animal IGRT systems operate at x-ray tube potentials at or below 225 kVp
to produce a photon beam with dosimetric properties (depth dose, buildup, beam penumbra,
etc.) that are appropriate for the size of experimental animals.1 Supporting small animal treat-
ment planning systems, often incorporating Monte Carlo dose engines, are available to further
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advance the sophistication of radiotherapy in small animals.2,3 However, accurate dose calcu-
lations in small animals remain a challenge.2,4 With kilovoltage beams, small animal IGRT
systems deposit energy through both photoelectric and Compton interactions. With clinical
megavoltage beams, photoelectric interactions can generally be ignored. To accurately model
photoelectric interactions, knowledge of both the tissue elemental composition and the tissue
density is needed. The elemental tissue composition is often quantified by the effective atomic
number (Zeff ) as defined by Johns and Cunningham.5 Since human tissue compositions have
been characterized,6,7 but not for small animals, we have assumed small animal and human
tissue compositions are equivalent in calculating small animal dose.3,4,8
Previously, Bazalova and Graves have shown that a larger set of tissues of varying elemental
composition is needed for more accurate small animal dose calculation.4 The most straightfor-
ward approach is to create finer density bins with corresponding tissue compositions. This
works well for bone since bone density essentially increases with increasing amounts of bone
apatite.8 However, there are many soft tissues with similar density but different compositions.
For example, the standard human tissue compositions9 of Lymph, GI Tract, and Red Marrow
have an identical density of 1.03 g/cm3, but dissimilar elemental compositions as shown by
their corresponding effective atomic numbers (Zeff ) of 7.6, 7.5, and 7.2. Such an unaccounted
5% difference in Zeff results in a dose variation from 0.87 to 1.01 for the three tissues (lymph, GI
tract and red marrow) relative to muscle for a 120 kVp therapy beam (mean energy at 55 keV).4
This difference is greater than 10% and is unaccounted for when using a single energy CT scan
for dose calculation with kV therapy beams.
Dual energy computed tomography (DECT) has the potential to overcome some of the
limitations in small animal dose calculation by providing elemental composition information in
addition to density. DECT has been proposed to estimate the elemental composition of tissue in
the human/clinical setting10,11 and improve kilovoltage dose calculation accuracy. Specifically,
DECT has been studied for low energy brachytherapy12 and ion therapy.13
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Currently, little to no work has been published related to the use of dual energy micro-
CT (DEmCT) to estimate the elemental composition of tissue to improve dose calculation for
small animal radiotherapy studies. Micro-CT differs from clinical CT scanners in several ways.
First, the kVp is lower and x-ray spectra softer for a micro-CT compared to a clinical CT, as
the sizes of the scan subjects are different. The factory maximum kVp of a common micro-CT
(the GE eXplore CT 120, GE Healthcare, Milwaukee, WI) is 110 kVp, with a beam filter of
4.5 mmAl. Clinical DECT scanners most often use 140 kVp as the high energy. One dual
source dual energy CT scanner (Somatom Definition Flash, Siemens Healthcare, Forchheim,
Germany) has a base filter composed of 3.0 mmAl and 0.9 mmTi applied to the low energy (e.g.
100 kVp) beam, with an additional 0.4 mmSn applied to the high energy (140 kVp) beam.14,15
One study added 9 mmAl to the filter for the 100 kVp and 140 kVp beams to reduce beam
hardening and improve Zeff measurement accuracy.10 A micro-CT cannot match the spectra of
a clinical scanner. Therefore, different spectral pairs will need to be examined for DEmCT.
Secondly, micro-CT based on a cone-beam geometry will generally have lower image quality
compared to fan beam clinical CT.
This study experimentally investigates dual-energy micro-CT (DEmCT) to be applied to
tissue classification for small animal kilovoltage Monte Carlo dose calculation. In this work,
an adaptation of an image-space DECT algorithm10,11 to a small animal cone-beam micro-CT
(GE eXplore CT 120) is presented with a new DEmCT energy pair of 70 kVp (4.5 mmAl) and
120 kVp (4.5 mmAl + 1 mmCu). The impact of imaging reconstruction artefacts (systematic
uncertainties) and imaging noise (random uncertainties) on the effective atomic number and
relative electron density as determined by DEmCT is investigated. We designed phantoms
specifically to evaluate the application of DEmCT for tissue classification. These phantoms
covered an extensive range of materials, some with similar densities but different effective
atomic numbers, and are sized to investigate beam hardening effects. Finally, a proof of concept
scan of a mouse is performed and analyzed.
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3.2 Methods
3.2.1 Micro-CT scanner and image acquisition
Images were acquired on a modified GE eXplore CT 120 (GE Healthcare, Milwaukee, WI).
A computer controlled filter wheel was installed to allow the easy addition, and subsequent
removal, of 1 mm of copper to the beam filtration. Two x-ray tube potentials were used, 70
and 120 kVp, with the 120 kVp beam hardened with the addition of 1 mm copper filtration
to the base filter of 4.5 mm aluminum. The additional 1 mm of copper to the 120 kVp scan
increased the separation between the two scan mean energies. The system modifications, such
as the upgraded generator, were described previously.16 The detector is composed of a CsI
scintillator atop a fibre optic taper bonded to a CCD.
Acquisition settings for the scans were 900 projections, full gantry rotation, 16 ms expo-
sure, with 4 × 4 detector pixel binning and gain and offset settings of 70 and 20, respectively.
The 70 kVp scans were run at 32 mA, and the 120 kVp scans at 63 mA to compensate for the
additional 1 mmCu filter. The x-ray tube current was chosen as the highest mA setting that
would not saturate the detector during a bright field acquisition with no object in the scanner.
The large focal spot (1 mm) was used for all scans. Scanning dose was measured with a 0.6 cm3
Farmer chamber (type 30013, PTW, Freiburg, Germany) in a 2 cm diameter PMMA cylindrical
phantom. The doses for the 70 kVp and 120 kVp scans were 8.2 cGy and 9.1 cGy, respectively.
Approximately ten minutes of CT scanning time was required for a dual energy acquisition.
Images were reconstructed at 0.2 × 0.2 × 0.5 mm3 using the manufacturer supplied cone-beam
filtered back-projection (FDK) algorithm. A median filter (5 × 5) was applied to the CT axial
image slices to obtain an average image noise of 15 and 12 HU for 70 and 120 kVp respec-
tively. All scans included a syringe or vial of water as a reference. Each scan was calibrated
individually by delineating air and water regions in the scan and applying an offset and scaling
factor. The same scanning protocols were used for all objects. No adaptation of the mAs was
made to account for the size of the scanned object.
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3.2.2 Dual energy computed tomography algorithm
More detail on the dual energy algorithm is provided in appendix B. This work implements the
DECT algorithm described by Bazalova et al.10,11 with the addition of the modified formulation
of the effective atomic number of water, Zw, described by Landry et al.12,17 The algorithm uses
two CT images acquired at different x-ray tube potentials and models the x-ray spectrum and
detector response to generate maps of the effective atomic number (Zeff ) and electron density
relative to water (ρe/ρe,w). Details can be found in Bazalova et al.11 and Landry et al.12 To adapt
the algorithm to the micro-CT from that of a clinical CT scanner, the micro-CT x-ray spectra
and detector response are needed. The x-ray spectra were simulated using BEAMnrc,18 a pack-
age of EGSnrc.19,20 The Monte Carlo simulation parameters were described previously.16 The
detector response was modelled as a CsI scintillation crystal doped with Tl. Crystal response
data from Mengesha et al.21 was used to adjust the detector signal integration of the x-ray
spectrum used by the algorithm. The thickness of the detector scintillator is unknown; a typi-
cal thickness of 0.15 mm was used. Theoretical values for effective atomic number (Zeff ,theory)
were calculated using the empirical power law with an exponential power of 3.5.5
3.2.3 DECT scanning objects
3.2.3.1 CIRS and Gammex phantom inserts
Tissue-equivalent inserts, with an average diameter of 2.8 cm, from two CT electron density
calibration phantoms, Gammex Model 467 (Gammex, Middleton, WI) and CIRS Model 062
(CIRS, Norfolk, VI), were scanned (table 3.1).
3.2.3.2 Micro-CT specific plastics and solution phantoms
We constructed four cylindrical (one 6.08 cm diameter and three 2.54 cm diameter) PMMA
phantoms with ten different plastics inserts of varying elemental composition and density (ta-
ble 3.2). Additionally, four phantoms consisted of vials of solutions with varying concentration
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Phantom Insert Density (g/cm3) ρe/ρe,w Zeff ,theory
Gammex Inserts
LN-300 Lung 0.300 0.290 7.65
LN-450 Lung 0.450 0.440 7.62
AP6 Adipose 0.940 0.930 6.40
BR-12 Breast 0.980 0.960 7.09
CT Solid Water 1.020 0.990 7.92
BRN-SR2 Brain 1.050 1.040 6.14
LV1 Liver 1.100 1.060 7.92
B200 Bone Mineral 1.150 1.100 10.70
SB3 Cortical Bone 1.820 1.690 13.88
CIRS Inserts
Lung (Inhale) 0.195 0.190 6.97
Lung (Exhale) 0.495 0.489 7.68
Adipose 0.960 0.952 6.52
Breast (50% Gland, 50% Adipose) 0.991 0.976 7.01
Plastic Water 1.016 1.001 7.79
Muscle 1.062 1.043 7.79
Liver 1.071 1.052 7.78
Trabecular Bone (200 mg/cc HA) 1.161 1.117 10.60
Dense Bone (800 mg/cc HA) 1.609 1.512 13.10
Table 3.1: Clinical electron density phantom inserts. CT density phantom insert material
values for physical density and relative electron density are from manufacturer data. Insert
material effective atomic number was calculated using manufacturer elemental composition
data.
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Material Molecular Formula Density (g/cm3) ρe/ρe,w Zeff ,theory
Plastics
Polypropylene (PP) (C3H6)n 0.86 0.88 5.53
High-density polyethylene (C2H4)n 0.95 0.98 5.53
(HDPE)
Acrylonitrile butadiene (C15H17N)n 1.00 0.97 5.81
styrene (ABS)
Polystyrene (PS) (C8H8)n 1.05 1.02 5.74
Nylon 6/6 (C12H22N2O2)n 1.16 1.13 6.21
Polycarbonate (PC) (C16H14O3)n 1.21 1.15 6.33
Poly(ethylene terephtalate) (C16H18O4)n 1.27 1.22 6.41
glycol-modified (PETG)
Polyvinyl chloride (PVC) (C2H3Cl)n 1.30 1.20 14.26
Polyoxymethylene (POM, (CH2O)n 1.42 1.36 7.03
acetal, Delrin)
Polytetrafluoroethylene (C2F4)n 2.20 1.90 8.48
(PTFE, Teflon)
Poly(methyl methacrylate) (C5H8O2)n 1.18 1.15 6.56
(PMMA, acrylic)
Solutions
EtOH 100% C2H6O 0.79 0.80 6.47
EtOH 90% C2H6O 0.81 0.82 6.62
EtOH 75% C2H6O 0.84 0.85 6.82
EtOH 50% C2H6O 0.89 0.90 7.09
EtOH 25% C2H6O 0.95 0.95 7.32
EtOH 10% C2H6O 0.98 0.98 7.43
CaCl2 1 g/100 mL CaCl2 1.01 1.01 7.88
CaCl2 5 g/100 mL CaCl2 1.05 1.04 9.02
CaCl2 10 g/100 mL CaCl2 1.10 1.09 10.00
CaCl2 20 g/100 mL CaCl2 1.20 1.18 11.31
CaCl2 30 g/100 mL CaCl2 1.30 1.26 12.19
CaCl2 40 g/100 mL CaCl2 1.40 1.35 12.85
CaCl2 50 g/100 mL CaCl2 1.50 1.44 13.37
CaCl2 60 g/100 mL CaCl2 1.60 1.53 13.78
Table 3.2: Materials used in custom phantoms. Molecular formula corresponds to the primary
component of the plastic. Additives, such as stabilizers or dyes were not considered in the
calculation of the relative electron density or effective atomic number. Physical density values
are from supplier data sheets, and verified by measurement. Ethanol and calcium chloride
solutions were prepared with de-ionized water.
Chapter 3. Dual energy micro-CT 65
of ethanol or calcium chloride in water to test the accuracies of DECT. In particular, these phan-
toms were designed to allow us to investigate the impact of imaging artefacts (beam hardening
and streaking) as well as imaging noise on the determination of Zeff and ρe/ρe,w.
3.2.3.2.1 Plastics phantom design The two sizes of cylindrical phantoms, 2.54 cm (1′′)
and 6.08 cm (2′′) in diameter, were designed to investigate the impact of beam-hardening
artefacts on the measurement of Zeff and ρe/ρe,w. Beam hardening results in a cupping effect
where the HU in the centre of the phantom is depressed compared to the edges, and is more
pronounced in larger phantoms. The two sizes of phantoms allows for the comparison of
repeated insert materials within the larger phantom and the comparison of materials between
the large and small phantoms. Eleven plastics (10 insert materials and PMMA for the phantom
body) were used to construct the phantoms, and are listed in table 3.2. Most inserts were of a
diameter of 3.175 mm (1/8′′), except for POM with a diameter of 4.7625 mm (3/16′′) and HDPE
and polystyrene with a diameter of 6.35 mm (1/4′′). Variations in insert diameter were a result of
the supplier’s carried inventory. The large diameter PMMA phantom was designed to have an
outer ring of 12 inserts and an inner ring of 6 inserts (figures 3.1a, 3.1b). All ten insert plastic
materials were inserted into the outer ring, leaving 2 inserts as air. Four materials (PTFE, nylon,
polycarbonate and polyprolylene) were repeated in the inner ring with two left as air. Three
small phantoms containing the ten unique plastic inserts were constructed (figures 3.1c–3.1h).
Two small phantoms contained 4 materials and 2 air inserts and the remaining small phantom
contained only two largest diameter inserts (polystyrene and HDPE).
3.2.3.2.2 Solution phantom design To fill in some of the gaps in materials with different
compositions of Zeff and ρe/ρe,w, we also prepared a total of four solution phantoms (figure 3.2).
A Styrofoam vial holder with a capacity of 7 vials was manufactured. Two calcium chloride
(CaCl2) based phantoms (figure 3.2a) were prepared with 6 of 8 different concentrations of
CaCl2 solutions (table 3.2), plus one vial of water in each phantom. Four concentrations of
CaCl2 were repeated (60, 40, 10, and 5 g/100 mL) in these two phantoms. An ethanol (EtOH)
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Figure 3.1: Images of the plastics phantoms, with the main body constructed of PMMA.
Insert materials are labelled. Corresponding mid-phantom CT slices acquired at 70 kVp (a)
and 120 kVp (b) displayed with the same window and level.
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Figure 3.2: Images of the solutions phantoms with insert solutions labelled. For CaCl2 solu-
tions, the g/mL is labelled, and for alcohol (EtOH), the percentage EtOH by volume is labelled.
Corresponding mid-phantom CT slices acquired at 70 kVp (a), (c), (e) and 120 kVp (b), (d),
(f) are displayed with the same window and level.
based phantom, made of 6 vials of varying ethanol concentrations (table 3.2) plus one vial of
distilled water, was prepared (figure 3.2c). Upon imaging the CaCl2 solution phantom, the most
concentrated CaCl2 solutions (60 g/100 mL) generated a streaking artefact across the central
vial of 5 g/100 mL of CaCl2 (figure 3.2a). Therefore, a fourth solution phantom (figure 3.2e)
was constructed composed of one vial of 5 g/100 mL of CaCl2, one vial of water and one vial of
100% of EtOH. This fourth solution phantom was fabricated to eliminate the streaking artefact
affecting the 5 g/100 mL CaCl2 measurement, and to help quantify the systematic error from
streaking artefacts in the determination of Zeff and ρe/ρe,w from the CaCl2 solution phantoms.
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3.2.4 Small animal
A mouse was anesthetized with isoflurane, and imaged at 70 kVp and 120 kVp using the
same protocols for the phantoms as described previously. All procedures followed animal care
protocols approved by the Animal Use Subcommittee of The University of Western Ontario
and were consistent with the policies of the Canadian Council on Animal Care (CCAC). Im-
ages were acquired serially, with no adjustment of the subject between scans. To account for
intra-scan motion, the 120 kVp image was registered to the 70 kVp image using the General
Registration (BRAINS) module in 3D Slicer 4.2.2.22
3.2.5 Comparison with theoretical values
For each material in the phantoms, the theoretical Zeff and ρe/ρe,w were calculated and tabulated
in tables 3.1 and 3.2. For the CIRS and Gammex inserts, an average HU value for each insert
was calculated by taking a region of interest that covered the cross-section of each insert,
excluding partial volume voxels at the periphery. The averaged HU pairs for each insert were
used as input to the DECT algorithm to calculate a Zeff and ρe/ρe,w for each insert material. For
the plastics and solutions phantoms, an image slice was processed with the DECT algorithm
to produce Zeff and ρe/ρe,w images. The average values of the measured Zeff and ρe/ρe,w were
obtained by placing regions of interest on the images. We grouped our analysis into imaging
reconstruction artefacts (systematic uncertainties) and imaging noise (random uncertainties).
3.2.5.1 Impact of imaging artefacts (systematic uncertainties)
Beam-hardening effects were assessed in two ways: comparisons of materials within the large
(6.08 cm diameter) phantom and comparisons of materials between the large and the small
(2.54 cm diameter) phantoms. For the large phantom, the four inner inserts (PTFE, nylon,
polycarbonate and polypropylene) and the phantom body (PMMA) were compared to their
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counterparts in the outer ring. All ten insert materials and PMMA were compared between the
large phantom (outer and inner rings) and the small phantoms.
3.2.5.2 Impact of imaging noise (random uncertainties)
We isolated variation due to imaging noise from systematic uncertainties due to streaking and
beam hardening reconstruction artefacts by analyzing regions of interest in the small plastics
phantoms and solution phantoms with concentrations of CaCl2 less than 5 g/100 mL. Twenty-
one regions of interests were employed for this investigation, with 11 in the plastics group, and
10 in the solutions group. Imaging noise is characterized by the standard deviation of the HU
in the regions of interest. The 70 kVp and 120 kVp images were analyzed before and after a
5 × 5 median filter was applied to the axial slices of the CT. The Zeff and ρe/ρe,w images are
calculated from both the filtered and unfiltered CT HU images. The median, minimum and
maximum standard deviations for the CT HU (70 and 120 kVp), Zeff and ρe/ρe,w are reported
separately for the plastics group and the solutions group. This will allow us to evaluate the
impact of HU random uncertainties from imaging noise on the uncertainties in Zeff and ρe/ρe,w.
3.2.6 DECT for small animal
The dual energy algorithm was applied to generate Zeff and ρe/ρe,w images for the mouse. These
images were qualitatively examined to provide a first look at limitations and benefits of the dual
energy algorithm that cannot easily be demonstrated in phantoms.
3.3 Results
3.3.1 Phantom scans
Dual energy CT images of the large and small plastics phantoms and representative solution
phantoms are shown in figures 3.1 and 3.2 respectively. Corresponding Zeff and ρe/ρe,w images
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are shown in figures 3.3 and 3.4. Measured Zeff and ρe/ρe,w against their corresponding the-
oretical values are shown in figure 3.5 for all phantom materials, including CIRS, Gammex,
plastics and solutions. For materials above Zeff ,theory of 8, there is a trend for the measurement to
underestimate the Zeff . Specific data on each group of phantoms are plotted for plastics phan-
toms (figure 3.6), calcium chloride (figure 3.7) as well as ethanol solutions and the clinical
electron density inserts (figure 3.8). In general, the small plastics phantoms agreed better with
theoretical values compared to the large phantom. The ethanol solutions agreed better than the
calcium chloride solutions because of their effective atomic numbers. Detailed quantification
is presented below.
The small plastics phantoms (figure 3.6) generally showed good agreement with theoret-
ical calculations, with 8 of 11 Zeff percent differences less than 3.5%, and a median percent
difference of 1.65%. For the large plastics phantom (figure 3.6), the results are generally worse
compared to the small phantoms, with a median Zeff percent difference of 5.3% and 6.0% for
the inner and outer rings. For the outer ring, 5 of 11 materials have a Zeff percent difference
of greater than 10%. The small and large plastics phantoms are made of identical materials.
Some outliers, such as PVC and PTFE are common to both phantom sizes and the difference is
related to the material (figure 3.6e). Of note, HDPE, PS and ABS have Zeff percent differences
of 1.3, 0.7 and 1.2% in the small phantoms, but 10.3, 11.9 and 11.6% in the large phantoms
respectively (figure 3.6e). This systematic error in the large phantom is attributed to beam
hardening due to difference in phantom size. Relative electron density measurements in the
plastics phantoms have median percentage differences of 4.6, 3.6 and 3.0% for the small, large
outer and large inner plastics.
The calcium chloride solutions were consistently underestimated in Zeff by the measure-
ment algorithm (figure 3.7e). The largest mean relative electron density percent difference
was 3.5% (figure 3.7f). The ethanol solutions show good agreement with theoretical calcu-
lations, with all Zeff measurements with a percent error less than 3.5%, and median of 1.9%
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Figure 3.3: Effective atomic number (a), (c), (e), (g) and relative electron density (b), (d), (f),
(h) are shown for the same slice of the large and small plastics phantoms. Material labels are
shown in figure 3.1.
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Figure 3.4: Effective atomic number are shown in (a), (c), (e) and relative electron density (b),
(d), (f) for the solution phantoms. Insert materials are vials of solutions labelled in figure 3.2.
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Figure 3.5: Combined phantom results are shown for small and large plastic phantoms, ethanol
and calcium chloride solutions, CIRS and Gammex inserts. Error bars are the standard devia-
tion of the voxel values in the ROI. Theoretical versus measurement values of effective atomic
number (a) and relative electron density (b) are plotted with a dashed unity line. Note a linear
correction is applied to the CCD detector data in chapter 4 that was not applied here.
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Figure 3.6: Comparison of Hounsfield units scanned at 70 kVp (a) and 120 kVp (b), effective
atomic numbers (Zeff ) (c), relative electron density (ρe/ρe,w) (d), relative errors of Zeff (e) and
ρe/ρe,w (f), of material inserts inside the plastic phantoms. Materials are labelled according
to names defined in table 3.2. The materials in the larger phantom are labelled to indicate
whether the materials are in the outer (“Large Outer”) or inner (“Large Inner”) rings. They are
compared to those inside the smaller phantoms. Error bars indicate the standard deviation of
the pixels within the regions of interest.
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Figure 3.7: Comparison of Hounsfield units scanned at 70 kVp (a) and 120 kVp (b), effective
atomic numbers (Zeff ) (c), relative electron density (ρe/ρe,w) (d), relative errors of Zeff (e) and
relative errors of relative electron density ρe/ρe,w (f), of CaCl2 solutions. Indicated in the plots
are the amounts of CaCl2 in g/100 mL in the solutions. Multiple bars per concentration indicate
a repeated measurement. Error bars indicate the standard deviation of the pixels within the
regions of interest.
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Figure 3.8: Relative differences in effective atomic numbers (Zeff ) and relative electron density
(ρe/ρe,w) for ethanol solutions (a,b), CIRS inserts (c,d) and Gammex inserts (e,f). Multiple bars
per material indicate a repeated measurement. Error bars indicate the standard deviation of the
pixels within the regions of interest.
(figure 3.8a). Relative electron density was good as well, with all measurements within 2.5%
(figure 3.8b).
The clinical electron density inserts (figures 3.8c–3.8f), 13 of the 19 scanned inserts had a
percent difference in Zeff less than 5%, with a median of 2.7%. For relative electron density,
16 of the 19 had a percent difference less than 5%, with a median of 1.21%. Bone inserts
accounted for 4 of 6 inserts with Zeff differences greater than 5% with the most significant
deviation (SB3) discussed below.
3.3.1.1 Imaging arefacts
Two of the largest errors can be attributed to streaking artefacts affecting the 5 g/mL CaCl2
solution when it was placed at the center of the phantom (figure 3.2a). The streaking artefact
caused a depression in the estimation of the Zeff , as shown in figure 3.7e. In figure 3.5a, we see
that the Gammex SB3 insert did not fall on the same linear trend as the other materials above
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Small Plastics Phantoms EtOH Phantoms
70 kV HU CT HU Unfiltered 14.2 10.8
std dev (11.7–40.8) (9.7–14.3)
CT HU Median Filtered 6.1 3.6
(5.0–39.7) (3.2–5.4)
120 kV HU CT HU Unfiltered 25.7 17.7
std dev (21.6–31.1) (17.11–22.9)
CT HU Median Filtered 8.3 5.8
(5.8–24.4) (4.9–8.4)
Zeff CT HU Unfiltered 0.365 0.280
std dev (0.122–0.430) (0.182–0.472)
CT HU Median Filtered 0.110 0.078
(0.049–0.129) (0.062–0.140)
ρe/ρe,w CT HU Unfiltered 0.0348 0.0258
std dev (0.0308–0.0401) (0.0249–0.0329)
CT HU Median Filtered 0.0119 0.0082
(0.0084–0.0260) (0.0070–0.0111)
Table 3.3: Comparisons of uncertainties in effective atomic number (Zeff ) and relative electron
density (ρe/ρe,w) in conjunction with imaging noise (in HU) with and without median noise
filtering in the HU images. Reported values are the median (minimum–maximum) standard
deviations (std dev) of the respective quantity of interest within regions of interests in the small
plastic phantoms and the EtOH solution phantoms.
a Zeff of 8, which we attributed to the phantom size and relatively high attenuating materials,
increasing beam-hardening effects.
3.3.1.2 Imaging noise
Table 3.3 summarizes the change in the noise of Zeff and ρe/ρe,w before and after the application
of a 5 × 5 median filter on the CT HU data. Reduction of the CT HU noise leads to a similar
reduction of noise in Zeff and ρe/ρe,w. Examination of the mean Zeff and ρe/ρe,w before and
after the application the median filter yielded a mean absolute difference of 0.2% for both
parameters.
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Figure 3.9: Axial CT images acquired at 70 kVp of a mouse at the diaphragm (a) and head
(d). Corresponding Zeff (b,e) and relative electron density (c,f) images are also shown.
3.3.2 Small animal scan
The results of the mouse scan are presented in figure 3.9. Looking at the diaphragm axial slice,
the breathing motion artefact is apparent in the CT image (figure 3.9a) that causes a gradient in
the lung boundary. This artefact is apparent in the relative electron density image (figure 3.9c).
However, the Zeff image (figure 3.9b) shows a nearly uniform effective atomic number across
the diaphragm interface in contrast to the CT and relative electron density. For the skull images,
artefacts from residual motion and beam hardening are apparent, especially in the Zeff image
(figures 3.9d–3.9f).
3.4 Discussion
Beam-hardening effects are apparent from the results of the large and small plastics phan-
toms (figure 3.6). The small plastics phantoms scan results agree better with theoretical values
compared to the same materials scanned in the larger plastics phantoms. The spectrum of
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this micro-CT is sufficiently soft that additional beam hardening corrections are needed to im-
prove the accuracy when scanning larger specimens. Additional physical filters to harden the
x-ray beam would also improve systematic errors due to the x-ray spectrum. Streaking arte-
facts from high Zeff materials are problematic, as best illustrated by the streak crossing the 5 g
CaCl2/100 mL vial in figure 3.2a. The artefact leads to an artefact in the Zeff image (figure 3.4a)
and subsequently large error shown in figure 3.7e. For this particular micro-CT scanner, the
1 mm of copper was the most attenuating filter we can employ without substantially increasing
beam-on time while keeping reasonable imaging noise.
A median filter was employed to reduce imaging noise to a desirable level while maintain-
ing a scanning protocol with reasonable spatial resolution, imaging radiation dose and scan
time. As shown in table 3.3, reducing the noise in the CT images proportionally reduced the
noise in Zeff and ρe/ρe,w by roughly the same amount. The application of the median filter did
not change the mean value of Zeff and ρe/ρe,w for each material scanned and suggests imaging
noise does not strongly affect the accuracy of the values of effective atomic number and rel-
ative electron density. However, image noise post-processing is not equivalent to changes in
image noise resulting from increased or decreased radiation dose used to acquire the image.
To answer the question of how imaging noise (dose) affects DEmCT accuracy for determining
Zeff and ρe/ρe,w will require a dedicated study to acquire additional data.
While much work has been done on DECT on clinical scanners, little has been published
on dual energy scans in micro-CT. The relative electron density measured in this study by
micro-CT has an accuracy slightly worse compared to previous work on clinical scanners.23
The measured relative electron density of 85% of the materials we scanned agreed within 5%
of their theoretical values. The results of Zeff of this study are comparable to previous work
on clinical scanners10,11,17,24–26 if we restrict the comparison to materials with a Zeff less than 8,
and exclude measurements suffering from beam hardening effects.
Based on figure 3.5a, it’s clearly apparent a calibration correction should be applied for
materials with a Zeff larger than 8. However, materials suitable for calibrating are not evident.
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The clinical electron density inserts provide a good range of tissue like materials with known
composition, but they are too large for a micro-CT. Only a few inserts can be scanned at a time
in a time inefficient process. More importantly, the size of the inserts causes systematic beam
hardening effects, especially for high Z materials. Figures 3.5a and 3.8e show the SB3 insert
does not follow the same trend as the CaCl2 solutions. A calibration based solely on the clinical
inserts would not be desirable, for either the traditional single energy CT to density method, or
for a correction/verification of a dual-energy CT method. The solutions provided a good range
of Zeff values and we can be confident in their composition. However, they are not practical as
they need to be reconstituted for each scan as their stability over time is limited by evaporation.
The plastics have good stability and are easily assembled into differently sized phantoms to
investigate beam hardening. However the range of Zeff is limited in the plastics, with most
falling in the low Zeff adipose range and few in the water and bone ranges. Additionally,
the composition of the plastics is not well known, relying on manufacturer’s specifications.
A micro-CT phantom composed of a wide range of well known, stable, tissue mimicking
materials, potentially in a few sizes, should be built. A scaled down CIRS Model 062 or
Gammex Model 467 would be ideal.
The mouse scan demonstrated several effects that are not seen in a stationary phantom scan.
Motion artefacts between the high energy and low energy scans cause artefacts, especially at
air-tissue interfaces. Immobilization and registration should be considered to improve DECT
performance on animals without fast kV switching or dual source scanners. One benefit is
that the DECT algorithm can better classify the tissue Zeff in a region of respiratory motion.
A motion induced density gradient in the lung image would often lead to lung and other soft
tissues erroneously being assigned to adipose tissues. In our pilot scan, the diaphragm region
was uniformly shown with a Zeff in the range of lung/muscle/liver as opposed to adipose, had
a density to Zeff method been used. However, the electron density image shows a respiratory
motion artefact. We hypothesize that while the apparent density in the diaphragm region is
reduced in both low and high energy scans from DECT, the ratio between the two energy scans
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remains similar. This preserves the Zeff information. Given the electron density images are
sensitive to motion, gated acquisition or reconstruction should be considered for thoracic and
abdominal studies.
3.5 Conclusion
We have adapted, implemented and evaluated a dual energy image-space algorithm developed
for clinical CT for measuring effective atomic number and electron density in micro-CT. We
found the measured and theoretical ρe/ρe,w values agreed with median percent difference less
than 2.5%. The measured and theoretical Zeff values agreed with median percent difference
less than 3.0% for Zeff less than 8, while measurement systematically underestimated theoreti-
cal values for Zeff greater than 8 which can be corrected by a calibration. The small phantoms
had better agreement than the large phantom with 8 of 11 versus 2 of 16 material measure-
ments having Zeff percent differences less than 3.5%. Overall, the effective atomic number and
relative electron density determinations made with micro-CT are comparable in accuracy to
previous DECT work with clinical CT if one restricts the comparison to the small phantoms
and materials with Zeff less than 8. None of the phantoms presented in this study were ideal,
but together covered a large range of requirements. Ideally, scaled down versions of the clin-
ical electron density phantoms should be constructed that would address multiple calibration
phantom requirements in a single phantom. To our knowledge, this is the first application of
a dual-energy algorithm in the literature to measure the effective atomic number and relative
electron density on a micro-CT scanner. Our study showed beam hardening, imaging noise,
and motion artefacts that are more prevalent in micro-CT than clinical CT to be the major
challenges of DEmCT. Future investigations into reducing imaging noise, beam hardening and
motion artefacts in small animal imaging will enable DECT to be readily applicable with con-
fidence.
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Chapter 4
Improved determination of effective
atomic numbers and electron densities
using dual energy micro-CT with
optimized spectra and CMOS panel
detector
This chapter was adapted from the research article “Improved determination of effective atomic
numbers and electron densities using dual energy micro-CT with optimized spectra and CMOS
panel detector by M. D. Jensen, S. Dawson, J. Chen and E. Wong.
4.1 Introduction
Small animal radiation therapy is a growing field which investigates cancer in a preclinical
setting with sophisticated techniques such as image guidance, intensity modulation, and treat-
ment planning that are available in the clinic.1,2 Accurate radiation dosimetry is necessary in
preclinical small animal radiotherapy studies. Small animal radiation dosimetry is challenged
by kilovoltage x-ray therapy beams and micro-CT imaging limitations.
Kilovoltage x-rays (< 225 kVp) are generally used for small animal radiotherapy, in con-
trast to the megavoltage beams used for human external beam therapy. Kilovoltage x-rays
deposit dose through photoelectric and Compton interactions requiring knowledge of both ele-
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mental composition and electron density to accurately compute the dose.3 Dual energy CT can
provide elemental composition information that is needed to model photoelectric interactions
accurately in small animals. So far, limited work has been done on dual energy micro-CT for
dose computation.
In general, micro-CT scanners have a lower maximum x-ray accelerating potential than
clinical scanners. Micro-CT often has softer spectra, as they are not as strongly filtered. For
example, the GE eXplore CT 120 (GE Healthcare, Milwaukee, WI) has a maximum kVp of
110 kV and 4.5 mmAl filter, while most clinical scanners are capable of 140 kVp and have
stronger base filters (3.0 mmAl + 0.9 mmTi).4,5 Furthermore, investigations at improving clin-
ical DECT have increased the beam filtering, further separating the x-ray spectra from that
used in micro-CT.4–8 Therefore beam hardening related cupping and streaking artefacts are of-
ten present in micro-CT images and it becomes a challenge to implement DECT methods that
have been demonstrated with clinical CT scanners with better image quality.
The majority of DECT methods were developed and evaluated on clinical CT scanners, and
can be classified into projection-space or image-space approaches. In this paper, we investigate
DECT approaches for measuring electron density and elemental composition in small animals
using a micro-CT scanner equipped with a factory-installed CCD and a newer CMOS x-ray
detector.
To reduce beam hardening artefacts, projection-space DECT methods have been used to de-
compose the projection measured attenuation into thicknesses of two basis materials. Alvarez
and Macovski first showed decomposition into theoretically pure photoelectric and Compton
materials,9 while Lehmann et al. showed any two materials could be used as a basis.10 Virtual
monoenergetic images created from the basis material images can be used to improve contrast
for diagnostic tasks.11,12 Taschereau et al. implemented a projection space DECT algorithm on
a micro-CT using x-ray spectral information and a Newton-Raphson solver.13
Alternatively, image-space DECT methods can be used where the projections from the
two energies are first reconstructed separately into two image volumes. The resultant image
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volumes are then processed with a dual energy algorithm. Image-space DECT can be easier
to implement, especially if there is no access to the projection data. One spectral method
solves for the effective atomic number (EAN) and relative electron density (RED) by using x-
ray spectra information and the pair of CT image values.6,7,14–16 Torikoshi et al. published this
method using synchrotron monoenergetic CT images.14 Subsequently, Bazalova et al. extended
the algorithm to clinical CT scanner acquired polyenergetic CT images and the algorithm was
further improved by Landry et al.6,7,15,16 Other methods have been published by Heismann
et al., Goodsitt et al., Van Abbema et al., Landry et al., Hu¨nemohr et al., and Bourque et
al.17–23 Generally, they determine a number of model parameters from a calibration exercise,
with some having a theoretically based model, such as the Rutherford parameterization,24 and
others with empirical models. Tremblay et al. compared projection based sinogram methods
with the image space method by Bourque et al. with virtual mono-energetic images.25 This
paper compares two image-space methods, the spectral method by Bazalova et al. and the
the empirical method outlined by Bourque et al., which respectively will be referred to as the
spectral DECT method and the polynomial fit DECT method.
In this study, we investigated micro-DECT by changing from a CCD x-ray detector to a
more sensitive CMOS panel detector and optimized the x-ray beam quality to reduce beam
hardening related artefacts. The more sensitive CMOS allowed heavy filtration of the beam
with sufficient signal for an image. First we optimized the x-ray beam parameters and filtration
to create a pair of narrow x-ray spectra with maximal separation for DECT acquisition. We
then compared the performance of the CMOS detector with improved x-ray beam quality to the
performance of the previous CCD detector and x-ray beam quality for effective atomic number
and relative electron density measurements. Both the spectral and the polynomial fit DECT
methods are applied to the CCD and CMOS detector data. Secondly, we investigated using
virtual monoenergetic images with the spectral and polynomial fit DECT methods to further
reduce beam-hardening effects and quantitatively assess the improvement of effective atomic
number and relative electron density measurements. The CMOS detector data were processed
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to create virtual monoenergetic images and polyenergetic images for DECT calculation using
both the spectral and polynomial fit DECT methods.
4.2 Methods
4.2.1 Micro-CT Hardware
Our lab has previously published on a GE eXplore CT 120 (GE Healthcare, Milwaukee, WI)
micro-CT that has been modified for small animal image guided radiation therapy.26 The fac-
tory standard detector is a CCD bonded to fibre optic taper with a CsI scintillator. A new
CMOS flat panel detector (Xineos 1313, TeledyneDALSA, Waterloo, Canada) was installed,
replacing the CCD detector and allowing us to compare scans from the two detectors. This
flat panel detector has a pixel pitch of 100 microns, is more sensitive (including a thicker CsI
scintillator) and has a faster readout: up to 45 fps with a CameraLink Interface. The scanner
with the new flat panel has an effective resolution at isocentre of 68 microns, reduced when
compared to the CCD detector with 30 microns at isocentre. The CMOS detector has a larger
axial field of view as the panel active area is square (131 mm × 131 mm), compared the CCD
that had an aspect ratio of approximately 23:35.
4.2.2 Spectrum Optimization (kVp, mAs and filter choice)
Materials that are widely available were considered for filters, and the possible x-ray tube
potentials were capped at 100 kVp as recommended by the CMOS manufacturer. The spectra
were initially simulated with Spektr27 for optimizing the choice of filter material and thickness.
Many simulations of spectra with various kVp, filter materials and thicknesses were considered
to minimize the overlap of two imaging spectra. Refinement of the optimization was performed
on the micro-CT by testing the leading candidate materials. Once the filters and corresponding
thicknesses had been chosen, the final spectra used for DECT processing were calculated with
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kVp Beam Mean mAs, Rotation Views × Scan Dose
Filter Energy focal spot mode frame avg time (rel. to
(keV) (min) 70 kVp)
CCD Low 70 4.5 mmAl 42.2 32 mA 16 ms Continuous 900 × 1 5 1
Energy Large
CCD High 120 4.5 mmAl + 75.8 63 mA 16 ms Continuous 900 × 1 5 1.2
Energy 1.0 mmCu Large
CMOS Low 60 4.5 mmAl + 45.8 63 mA 16 ms Step and 450 × 18 30 1.4
Energy 0.4 mmCu Large Shoot
CMOS High 100 4.5 mmAl + 77.4 50 mA 20 ms Step and 450 × 18 30 1.1
Energy 0.8 mmSn Large Shoot
Table 4.1: Scanning protocol characteristics.
BEAMnrc.28 The final filters chosen for both the low and high-energy beams are listed in
table 4.1.
4.2.3 Scanning protocols
The scanning protocols are summarized in table 4.1. For both detectors, the mAs was chosen
to maximize the detector signal intensity without saturation on a bright-field image with no
scanned object. Where possible, mA was increased first to maintain a short exposure time.
The mAs was kept constant for all scans of the same protocol and not varied to compensate for
scan object size. For the new CMOS detector, a step and shoot acquisition protocol with frame
averaging was chosen as the high sensitivity causes the detector to saturate at much lower doses
compared to the CCD. By taking multiple images at each projection angle and averaging, we
can better match the noise characteristics of the scanning protocols of the CCD detector acqui-
sition. The step and shoot acquisition also provides more consistent co-registration between the
low and high energy projections than the continuous rotation acquisition used with the CCD
detector.
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4.2.4 Image reconstruction and preprocessing
All volumes acquired with the CMOS detector were reconstructed using the FDK cone-beam
filtered back-projection implementation in RTK29 with default parameters at a resolution of
136.8 × 136.8 × 342.1 µm3. The volumes acquired with the CCD detector were reconstructed
with the manufacturer supplied FDK engine with a resolution of 198.7 × 198.7 × 496.8 µm3.
Each volume was individually calibrated in HU by segmenting reference water and air regions
and applying appropriate scaling and shift factors. All images were filtered with a median
filter (5 × 5) in the axial plane before subsequent DECT processing. After median filtering the
images had an average image noise of 13, 17, 12 and 13 HU for the 60, 100, 70 and 120 kVp
protocols, respectively.
4.2.4.1 Virtual monoenergetic image reconstruction
The projection class of dual energy methods can create effective/virtual monoenergetic im-
ages.9,10 Instead of using the spectrum and a non-linear solver to decompose the projections
into equivalent thicknesses of two basis materials as previously demonstrated for micro-CT,13
we used a calibration based method. We implemented a fast isotransmission lines and table
lookup method with the reduced calibration measurement method.30,31 Calibration was per-
formed with aluminum and solid water as the two basis materials. Twenty steps of aluminum
of 1 mm thickness and 25 steps of solid water of 2 mm thickness were scanned. Polyenergetic
projections were first processed and decomposed into aluminum and solid water thickness pro-
jections. RTK’s FDK implementation was then used to reconstruct aluminum and solid water
density volumes at the same resolution as the polyenergetic images. Effective virtual monoen-
ergetic images were then created at the mean energies of the polyenergetic spectra: 46 keV
and 77 keV. These virtual monoenergetic images are then treated the same as the polyenergetic
images with individual HU calibration and median filtering as described previously.
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Density (g/cm3) ρe/ρe,w Zmed ± ∆Zmed
Plastics
Polypropylene (PP) 0.86 0.88 5.43 ± 0.04
High-density polyethylene (HDPE) 0.95 0.98 5.43 ± 0.04
Acrylonitrile butadiene styrene (ABS) 1.00 0.97 5.76 ± 0.02
Polystyrene (PS) 1.05 1.02 5.69 ± 0.02
Nylon 6/6 1.16 1.13 6.14 ± 0.03
Poly(methyl methacrylate) (PMMA, acrylic) 1.18 1.15 6.50 ± 0.02
Polycarbonate (PC) 1.21 1.15 6.29 ± 0.02
Poly(ethylene terephtalate) glycol-modified (PETG) 1.27 1.22 6.36 ± 0.02
Polyvinyl chloride (PVC) 1.30 1.2 14.064 ± 0.001
Polyoxymethylene (POM, acetal, Delrin) 1.42 1.36 6.99 ± 0.02
Polytetrafluoroethylene (PTFE, Teflon) 2.20 1.9 8.467 ± 0.001
Gammex
LN-300 Lung 0.310 0.298 7.50 ± 0.03
LN-450 Lung 0.480 0.468 7.50 ± 0.03
AP6 Adipose 0.948 0.931 6.17 ± 0.03
BR-12 Breast 0.979 0.956 6.88 ± 0.03
CT Solid Water 1.016 0.987 7.66 ± 0.02
BRN-SR2 Brain 1.051 1.047 6.05 ± 0.03
LV1 Liver 1.09 1.059 7.66 ± 0.02
Inner Bone∗ 1.136 1.089 10.28 ± 0.02
B200 Bone Mineral 1.149 1.101 10.29 ± 0.02
CB2-30∗ 1.334 1.279 10.75 ± 0.01
CB2-50∗ 1.561 1.471 12.39 ± 0.01
SB3 Cortical Bone 1.823 1.695 13.50 ± 0.02
Table 4.2: Material Properties. Gammex inserts marked with ∗ were not scanned with the CCD
version of the micro-CT.
4.2.5 Test materials
Two sets of materials were used to evaluate the DECT performance. The first set consisted of
the material inserts from the Gammex Model 467 (Gammex, Middleton, WI) electron density
phantom. Twelve material inserts were scanned with the CMOS panel, and 9 of the 12 were
previously scanned with the CCD. The second material set was four custom plastics phantoms:
3 small phantoms with a diameter of 2.54 cm (1′′) and one large phantom with a diameter
of 6.08 cm (2′′). The plastics phantoms consisted of a body of PMMA with 10 other plastic
inserts. The two sizes of phantoms allow for comparisons to investigate the effects of beam
hardening. All four plastics phantoms were scanned previously on the micro-CT with the CCD
detector and then rescanned with the CMOS panel. All the test materials are listed in table 4.2.
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4.2.6 Algorithms
More details on the dual energy algorithms are provided in appendix B.
4.2.6.1 Definition of effective atomic number
The gold standard effective atomic number used in this work is Zmed described by Bourque
et al.22 This method defines a lookup curve relating the electron cross-section to the atomic
number based on the X-COM database.32 The electron cross-section of a mixed material is
computed and the Zmed of the material is found using the lookup curve. The effective atomic
number Zmed was computed using the four x-ray spectra used for imaging (table 4.1) and the
therapy spectrum (140 kVp). The consensus Zmed value was computed by averaging the largest
and smallest value and the non-statistical variation (∆Zmed) was computed as half the difference
between the largest and smallest value. Zmed ±∆Zmed of our test materials are listed in table 4.2.
4.2.6.2 Spectral based DECT method
The image space spectrum method was implemented.6,7,14–16 A linear correction was applied
to the spectral method to reduce the error between measured EAN and theoretical Zmed values.
This linear correction was not applied in chapter 3. For the virtual monoenergetic images, the
same spectrum image space method is used, except with a single energy input for the spectrum.
Using virtual monoenergetic images emulates the original implementation of Torikoshi et al.
with a synchrotron-based scanner.14
4.2.6.3 Empirical polynomial fit DECT method
We implemented the method published by Bourque et al.22 Briefly, the dual energy ratio (DER:
ratio of the attenuation coefficients for the high energy to low energy scans) is computed for
each voxel of the image pair and regions of interest are applied to generate a mean DER for
each calibration material. A polynomial is fit to relate the theoretical effective atomic number
Zmed to the DER for all materials. Then another two polynomials, one for each energy scan,
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are fit to relate the theoretical relative electron density to the HU and Zmed. Both the high and
low energy scans are used to compute two relative electron density maps which are equally
weighted to create a final relative electron density map. This method can be optimized by
choosing the order of the polynomial. The order of the polynomial was chosen by trying
orders of 2, 4 and 6. Higher orders were rejected if they caused strong inflection points in the
range of the data or if the root mean squared error of the fit did not change markedly from the
lower order polynomial fit.
4.2.7 Analysis
For all volumetric scans, representative slices were selected from the volumes and regions of
interest were drawn on the various materials in the scan. The regions of interest were applied
as masks to the input CT images and the generated EAN and RED images to compute a mean
and standard deviation of each parameter for each material in each location.
4.2.7.1 Comparison of CMOS panel detector and optimized spectra with CCD detector
To compare the imaging performance between the CCD and CMOS detectors, polyenergetic
images from both detectors were compared with both the spectral DECT method and the poly-
nomial fit method. We specifically examined the plastics that were scanned in three positions:
large phantom inner ring, large phantom outer ring, and small phantom to compare and evalu-
ate beam-hardening effects. To evaluate how well the measurements agreed with the theoretical
Zmed values, the root mean squared error and the absolute mean and maximum residuals of the
linear correction of the spectral DECT method and the polynomial fit DECT method were ex-
amined. Residuals from the polynomial fit or spectral DECT correction are an indication of the
inconsistencies introduced by beam hardening artefacts.
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Figure 4.1: Plot of filtered spectrum used with the CCD detector and the CMOS detector.
CCD 70 kVp (4.5 mmAl) and 120 kVp (1.0 mmCu + 4.5 mmAl). CMOS detector 60 kVp
(0.4 mmCu + 4.5 mmAl) and 100 kVp (0.8 mmSn + 4.5 mmAl). All spectra normalized to the
unit area under the curve.
4.2.7.2 Comparison of polyenergetic images with virtual monoenergetic images
The same dual energy projection pairs acquired with the new CMOS detector were processed
into polyenergetic images and virtual monoenergetic images. Both sets of images were then
fed into the spectral DECT and polynomial fit DECT methods to generate four sets of EAN
and RED image volumes. The material regions of interest were used to generate a mean and
standard deviation of the EAN and RED for each material insert. The imaging noise and
difference between the measured and theoretical EAN and RED are investigated.
4.3 Results
4.3.1 Spectral Optimization
Figure 4.1 shows the simulated micro-CT spectrum for both the CCD and CMOS detectors.
Specifications of all the scanner protocols are presented in table 4.1. A copper filter of 0.4 mm
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Figure 4.2: Polyenergetic CT images of the large plastics phantom at 60 kVp (a) and 100 kVp
(b). The plastic inserts are labelled in (a). The CT images were processed with the polynomial
fit DECT method to produce the effective atomic number image (c) and relative electron density
image (d).
was chosen for the low energy 60 kVp scan, and a tin filter of 0.8 mm was chosen for the
high energy 100 kVp scan. The filter materials of copper and tin were chosen because they are
widely available and we were able to achieve reduction of overlap between the low-energy and
high-energy spectra.
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Figure 4.3: Polynomial fit calculated effective atomic number (a,b) and relative electron den-
sity (c,d) plotted against their theoretical values for the CMOS detector (a,c) and CCD detector
(b,d). Note a linear correction was applied to the CCD detector data (b,d) that was not applied
to the same data in chapter 3.
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Figure 4.4: Plots of the polynomial fits of the orders (2,4,6) for the CMOS and CCD detector
acquired data. Effective atomic number (EAN) is plotted against dual energy ratio (DER) of
attenuation coefficients for CMOS (a) and CCD (b). Low energy (LE) RED polynomial for
CMOS (c) and CCD (d) are plotted against EAN. High energy (HE) RED polynomial for
CMOS (e) and CCD (f) are plotted against EAN.
Chapter 4. Improved dual energy micro-CT with optimized spectra 97
4.3.2 CMOS versus CCD with polyenergetic images and polynomial fit
DECT method
Figure 4.2 displays a representative set of input polyenergetic images and the polynomial fit
output from the CMOS detector. Specifically, figure 4.2 presents a slice of the large plastics
phantom with polyenergetic 60 kVp and 100 kVp images and corresponding EAN and RED
images. To summarize the results for all phantom scans, figure 4.3 plots measured EAN and
RED against theoretical values for the CMOS and CCD polyenergetic image data processed
with the polynomial fit DECT method. Looking at the effective atomic number plots (fig-
ures 4.3a, 4.3b), we can see the high-Z Gammex inserts deviate from the unity line for the
CCD data, but not for the CMOS data. Additionally, at the low Z, the CMOS data points are
closer to the unity line than the CCD data. Polynomial fits of the EAN as a function of DER are
shown in figure 4.4 for the CMOS and CCD acquired data. For the CMOS detector, the EAN
and RED polynomials of order 4 were chosen to be employed. A higher order polynomial (6)
for the CMOS detector data did not improve the fit noticeably. For the CCD detector, best fits
for the EAN and RED polynomials were of order 2. Polynomial orders larger than 2 for the
CCD detector introduced over-fitting behaviour to accommodate outliers (figures 4.4b, 4.4d,
4.4f). Artefacts in the source images resulted in many deviations from a monotonic curve.
4.3.3 Polynomial versus spectral fit DECT methods
Table 4.3 lists the root mean squared errors, mean absolute residuals, and maximum absolute
residuals of the polynomial fit DECT and spectral DECT methods for the CMOS and CCD de-
tectors. The CCD detector has larger root mean squared errors and residuals compared to the
CMOS detector for both polynomial fit or spectral DECT methods. The polynomial fit DECT
and spectral DECT methods provide similar output when applied to the same input polyen-
ergetic CT images from the CMOS detector. In contrast, the polynomial fit DECT method
provides better output than the spectral method for the CCD detector.
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Polynomial fit Spectral
CCD CMOS CCD CMOS
Poly E Poly E V Mono E Poly E Poly E V Mono E
EAN RMSE 0.41 0.18 0.18 0.55 0.19 0.18
Mean Abs Residual 0.30 0.14 0.14 0.39 0.16 0.14
Max Abs Residual 1.3 0.52 0.53 2.10 0.48 0.39
RED RMSE Residual 0.062 0.033 0.033 0.115 0.050 0.054
Mean Abs Residual 0.042 0.025 0.025 0.084 0.036 0.038
Max Abs Residual 0.259 0.077 0.077 0.322 0.119 0.126
Table 4.3: Root mean square error (RMSE) and residuals of EAN and RED from the polyno-
mial fit DECT method and spectral DECT method.
4.3.4 CMOS monoenergetic versus polyenergetic; spectral versus poly-
nomial fit DECT method
Table 4.4 presents the noise in the input polyenergetic and monoenergetic images and the out-
put EAN and RED images for the CMOS data processed with both the spectral and polynomial
fit methods. There are minimal difference in the noise between the input virtual monoenergetic
images and the input polyenergetic CMOS acquired images. As well, the output images have
similar noise levels irrespective of the input data (virtual monoenergetic or polyenergetic) or
processing method (polynomial or spectral). Table 4.5 presents the accuracy of the four com-
binations of virtual monoenergetic and polyenergetic input images processed with the spectral
or polynomial fit DECT methods applied to the CMOS image data. Overall, there is little
difference between the accuracy of the four combinations.
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Input CT (HU) EAN RED
mean (max) mean (max) mean (max)
Poly E V Mono E Spectral Polynomial fit Spectral Polynomial fit
60 kVp 100 kVp 46 keV 77 keV Poly E V Mono E Poly E V Mono E Poly E V Mono E Poly E V Mono E
Plastics 13 17 13 18 0.32 0.33 0.30 0.32 0.025 0.024 0.017 0.019
(25) (28) (26) (28) (0.52) (0.53) (0.56) (0.57) (0.038) (0.036) (0.035) (0.040)
Gammex 36 28 37 28 0.60 0.60 0.60 0.61 0.042 0.041 0.043 0.043
(105) (99) (105) (99) (2.88) (2.89) (2.89) (2.91) (0.116) (0.116) (0.127) (0.127)
Table 4.4: Root mean square error (RMSE) and residuals of EAN and RED from the polynomial fit DECT method and spectral DECT
method.
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Precent difference from theory
mean (max)
Spectral Polynomial fit
EAN Plastics Polyenergetic 2.2 (7.1) 2.2 (5.5)
Virtual Monoenergetic 2.0 (7.3) 2.5 (5.8)
Gammex Polyenergetic 1.7 (4.4) 1.9 (5.3)
Virtual Monoenergetic 1.5 (4.8) 2.5 (5.1)
RED Plastics Polyenergetic 2.8 (8.3) 2.2 (4.9)
Virtual Monoenergetic 3.0 (10.3) 2.4 (6.6)
Gammex Polyenergetic 4.8 (30.9) 3.5 (12.6)
Virtual Monoenergetic 4.8 (28.4) 3.9 (12.8)
Table 4.5: Summary of percent difference between theory and measurement of EAN and RED
for material sets (Plastics and Gammex), input images sets (polyenergetic and virtual monoen-
ergetic) and DECT algorithms (Spectral and Polynomial fit) for the CMOS detector.
4.3.5 Beam hardening
Most of the difference between the CMOS and CCD data is related to beam hardening. Im-
provements in beam hardening artefacts are demonstrated in two ways. A reduction in the
cupping artefact is illustrated in figure 4.5 by plotting a line profile through images of the large
plastics phantom acquired with the CCD and CMOS detectors. Figure 4.6 shows the variation
in the CT HU values for 5 plastics that are scanned in 3 different locations. The variation
between the mean HU values for the three locations generally is larger for the CCD detector
(70 kVp and 120 kVp) compared to the CMOS detector (60 kVp and 100 kVp). This trend
is strongest for PTFE. Overall, the combination of the new CMOS detector and filtered x-ray
beams have reduced beam hardening related artefacts in the polyenergetic CT images.
4.4 Discussion
The addition of beam filters of 0.4 mm copper for 60 kVp and 0.8 mm tin for 100 kVp have
narrowed and separated the spectra. Tin is used in some clinical CT scanners to filter the
high energy scan.4,5 Work by Saito has shown that high Z (57–83) metals can achieve optimal
spectra separation for DECT.8 Saito recommended tungsten for the low energy filter when
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Figure 4.5: An illustration of the reduction of the cupping artefacts in the large plastics phan-
tom. Axial CT slice of the phantom showing the position of the line profile (a). Line profiles
of the low energy CT image volumes with spectra of 70 kVp and 60 kVp (b). Line profiles of
the high energy CT image volumes with spectra of 120 kVp and 100 kVp (c).
Figure 4.6: Comparison of the difference in HU mean values for each location to the mean
of the group for 5 plastic materials. The plastics phantoms were scanned with the new CMOS
detector (60 and 100 kVp) and the old CCD detector (70 and 120 kVp). Error bars represent
the standard deviation inside the region of interest in HU. Insert locations are plotted in order,
left to right: large phantom inner ring, large phantom outer ring and small phantoms. Scanning
x-ray spectra are color coded.
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paired with a high energy tin filter in clinical dual energy scanners.5 However, the tube loading
requirements with current x-ray hardware and the cost of some K-edge filter metals prevent the
implementation. The characteristics of the micro-CT geometry with the more sensitive CMOS
detector and small objects allowed us to achieve nearly detector saturating photon flux with the
combination of a low 60 kVp setting and a 0.4 mm copper filter, negating the need for a higher
kVp with a K-edge tungsten filter.
We have shown a reduction in beam hardening artefacts by using narrower x-ray spectra,
made possible by a sensitive CMOS flat panel detector. This improvement comes at the price of
increased scanning time to achieve similar quantum noise and a reduced maximum resolution
(68 vs. 28 microns). However, the 28 micron CCD scan protocol was restricted to ex-vivo
specimens due to the lethal x-ray dose. The maximum resolution for living specimens was
approximately 50 microns. As the smallest practical irradiation field is 5 mm × 5 mm, 68 µm
resolution is acceptable to locate a 5 mm diameter tumour. For dose calculation, feature details
may be sacrificed for low noise and quantitative accuracy. We have made this trade-off to
improve the accuracy of EAN and RED images. The addition of stronger image smoothing
filters could further reduce the scanning time. Further investigations are needed into how input
image noise affects the output values of EAN and RED, including if differences in the noise
level between the low or high energy scans are important. Projection images acquired with
the CCD required a correction for a honeycomb pattern and spatial distortions introduced by
the fibre optic taper. The CMOS flat panel does not require a distortion correction. Previously
with the CCD detector, setup with fluoroscopy was hindered by the obscuring honeycomb
pattern and distortions in the images as real-time correction is not computationally feasible.
By changing to the CMOS flat panel, the quality of the fluoroscopy images used for animal
setup has been improved.
The values of Zmed were calculated based on the x-ray spectra of the CT, and could vary
between micro-CT and clinical CT. However, the values of Zmed computed for the Gammex
Model 467 inserts using the micro-CT spectra agreed well with values corresponding to a
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clinical CT scanner spectra published by Bourque et al.22 Eleven of the thirteen insert materials
differed by less than their corresponding ∆Zmed (theoretically defined variation in EAN). The
two remaining materials of LN-300 and SB-3 Cortical Bone differed from the values published
by Bourque et al. by 0.047 and 0.013 respectively.
The Gammex inserts are a feasible set for calibration with the narrower x-ray spectra. The
EAN measurements of the large bone inserts now agree with the theoretical Zmed (figure 4.3a)
as beam hardening artefacts have been sufficiently supressed. However the lung inserts suffer
from partial volume effects because the air pockets are visible at the micro-CT scanning reso-
lution. Lung mimicking tissue inserts with smaller air pockets would be better for micro-CT.
In this work, virtual monoenergetic images generated from the CMOS acquired data pro-
vided no further improvement for EAN and RED measurement (table 4.5). The x-ray beam
spectra used with the CMOS detector are relatively hard and the decomposition algorithm is
simple. The generation of virtual monoenergetic images would likely have been beneficial
for the CCD system setup with softer spectra. Post-processing can be used to suppress beam
hardening effects instead of DECT methods, but were not examined in the present study. De-
composing the projections into materials with a larger separation in Z (solid water and iodine,
instead of solid water and aluminum) may improve the robustness of the material decompo-
sition.33 Solid water (plastic) and aluminum were chosen for practical reasons and was the
approach used in prior studies.30,31 The spectral DECT and polynomial fit DECT have simi-
lar accuracy. Since polynomial fit DECT is easier to calibrate, requires no information on the
spectra and detector response and is computationally simpler, it is the method recommended
by our study.
4.5 Conclusion
We have shown that beam hardening artefacts in a micro-CR/RT system were reduced with
a new CMOS detector and additional beam filters compared with the factory-installed CCD
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detector. With the polynomial fit DECT method, changing from the CCD to the CMOS de-
tector reduced the root mean square error (RMSE) from 0.41 to 0.18 for the effective atomic
number, and from 0.06 to 0.03 for the relative electron density. The image-space polynomial fit
and spectra DECT algorithms showed similar accuracy when applied to the same input CMOS
data, with RMSE of 0.18 versus 0.19 for effective atomic number and 0.03 versus 0.05 for rel-
ative electron density. In contrast, the polynomial fit method outperformed the spectral DECT
method for the CCD data with RMSE of 0.41 versus 0.55 for effective atomic number and 0.06
versus 0.12 for relative electron density. Polyenergetic and virtual monoenergetic images were
processed with two different algorithms to compute effective atomic number and relative elec-
tron density, and no differences in accuracy were found among the four possible combinations
of algorithms and images from the CMOS detector. With the CMOS detector, we were able to
determine effective atomic number with mean error less than 3% and relative electron density
with mean error less than 5%. Therefore we recommend the use of polyenergetic images ac-
quired by the CMOS detector and the polynomial fit algorithm for DECT using micro-CT/RT
system, as it is computationally simpler and faster than the spectral method. We have shown
that the determination of effective atomic numbers and electron densities with micro-CT can
be improved using a CMOS detector and optimized spectra compared to the factory-installed
CCD.
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Chapter 5
Conclusion and Future Work
5.1 Overview and Summary
Radiation therapy has advanced over the past few decades through major technological devel-
opments.1–6 The multi-leaf collimation technologies of Intensity Modulated Radiation Ther-
apy (IMRT) and the addition of on-board CT detectors for Image-Guided Radiation Therapy
(IGRT) have enabled the delivery of more localized radiation to complex geometric targets
with greater accuracy and precision.1,2,5,7–9 The next challenge will be to define the targets
using biological information using functional and molecular medical imaging.10,11 Preclinical
studies are an important aspect to the advancement of radiation oncology as the field moves
towards more biologically-based targeting and response monitoring.6 Preclinical studies are
also necessary to investigate the combination of new targeted drugs with targeted radiation
therapy.12 Therefore, the development of preclinical image-guided conformal irradiators and
techniques for small animal research are a critical component of enabling basic science stud-
ies that will test and form the hypotheses for clinical trials. While the clinical technology has
advanced, preclinical technology development has not kept pace. Many radiobiology studies
have been performed using wide-field irradiations of the whole or large fraction of the animal
body.13–16 Such irradiations do not mimic the conformal and image-guided treatments avail-
able for human-scale radiotherapy. As outlined by Verhaegen et al., a number of preclinical
image-guided systems have therefore been developed to address the gap between clinical and
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preclinical irradiation technology.13 Even with these new platforms, a number of limitations
were identified at the outset of this thesis. These include the maximum animal size amenable
to treatment in a micro-CT based system, production of asymmetric off-axis fields, complex
computerized collimation, respiratory beam gating, and dual-energy CT for use in Monte Carlo
calculation of dose distributions at kilovoltage energies. This thesis has addressed these issues.
In chapter 2, we presented the design, construction and commissioning of a set of computer-
controlled motorized jaws for a micro-CT/RT system in order to perform conformal image-
guided small animal radiotherapy. A system of custom-built motorized orthogonal jaws was
designed and evaluated, which allows the delivery of off-axis rectangular fields and enables
rat irradiation. Mechanical performance of the jaws was characterized using radiochromic
film and portal imaging. Square beam profiles ranging from 2 × 2 to 60 × 60 mm2 were
measured using EBT2 film in the center of a 70 × 70 × 22 mm3 solid water block. Similarly,
absolute depth dose was measured in a solid water and EBT2 film stack 50 × 50 × 50 mm3.
A calibrated Farmer ion chamber was used to measure the dose output of three field sizes:
50 × 50, 40 × 40, and 30 × 30 mm2. Elliptical cylinder target plans were delivered to films
to assess overall system performance. Respiratory-gated treatment was implemented on the
system and initially verified using a phantom subjected to simple sinusoidal motion. A Monte
Carlo beam model of the irradiator was created using BEAMnrc17 for comparison with the
measurements and manual dose planning. A sample image-guided partial lung irradiation in
a rat was demonstrated. The averaged random error of positioning each jaw was less than
0.1 mm. Relative dose output factors measured with the ion chamber agreed with Monte Carlo
simulations within 2%. Beam profiles and absolute depth dose curves measured from the films
agreed with simulations within measurement uncertainty. Respiratory-gated treatments applied
to a phantom moving with a peak-to-peak amplitude of 5 mm showed reduced beam penumbra
(80%–20%) from 3.9 to 0.8 mm. Overall, a set of computer-controlled motorized jaws for a
micro-CT/RT system were constructed with position reliably better than 0.1 mm. The hardware
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system was thereby characterized for image-guided conformal radiotherapy for small animals
adding the capability of respiratory-gated delivery.
In chapter 3, Dual-Energy CT (DECT) was developed for micro-CT in order to obtain tissue
electron density and effective atomic number data for improving dose computations at kilovolt-
age energy. The experimental investigations identified some challenges unique to dual-energy
micro-CT (DEmCT). Images were acquired sequentially at 70 kVp (4.5 mmAl) and 120 kVp
(4.5 mmAl + 1 mmCu). Four plastics phantoms (1 large, 3 small, 11 materials) and two so-
lution sets of CaCl2 and EtOH were designed for DEmCT. Additionally, 18 electron density
inserts and a mouse were scanned. Using a published clinical DECT algorithm, we found the
measured and theoretical relative electron density values agreed with a median percent differ-
ence less than 2.5%. The measured and theoretical effective atomic number values agreed with
a median percent difference less than 3.0% for effective atomic numbers less than 8, while mea-
surement systematically underestimated theoretical values for effective atomic numbers greater
than 8 which could be corrected by a calibration. The small phantoms had better agreement
than the large phantom with 8 of 11 versus 2 of 16 material measurements having effective
atomic number percent differences less than 3.5%; beam hardening was found to be the major
contributing factor to this discrepancy. Effective atomic number and relative electron density
maps were demonstrated in the mouse, despite motion and beam-hardening artefacts. Overall,
when beam-hardening and motion artefacts were minimized, the accuracies approached that of
modern clinical CT scanners.
In chapter 4, we quantified the improvements in dual energy micro-CT performance us-
ing a complementary metal oxide semiconductor (CMOS) x-ray detector panel in place of
a charge coupled device (CCD) detector. Four custom micro-CT phantoms with plastic in-
serts and commercial inserts with known material composition as used for clinical CT electron
density calibration were employed in this study. Dual energy image data of phantoms were
first acquired on a micro-CT with a factory-installed CCD detector using a pair of previously
optimized energy spectra. A CMOS panel detector was then installed and commissioned on
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the micro-CT/RT. Beam filters were then chosen and implemented by optimizing two x-ray
spectra for dual energy scans with the CMOS detector. Two published clinical dual energy
CT (DECT) image-space algorithms were implemented to determine effective atomic number
and relative electron density: an explicit spectra-based method and an empirical polynomial
fit method. Data obtained from the two detectors were processed with both DECT algorithms
and the effective atomic number and relative electron density of the various material inserts
were compared. We further tested the utility of virtual monoenergetic images in conjunction
with both DECT algorithms for the CMOS acquired data. The CMOS detector demonstrated
better accuracy and precision than the CCD detector with the polynomial fit DECT method, re-
ducing root mean square error (RMSE) from 0.41 to 0.18 for the effective atomic number, and
from 0.06 to 0.03 for the relative electron density. The image-space polynomial fit and spectra
DECT algorithms showed similar accuracy when applied to the same input CMOS data, with
RMSE of 0.18 vs. 0.19 for effective atomic number and 0.03 vs. 0.05 for relative electron den-
sity. In contrast, the polynomial fit outperformed the spectral DECT algorithm for the CCD
data with RMSE of 0.41 vs. 0.55 for effective atomic number and 0.06 vs. 0.12 for relative
electron density. Virtual monoenergetic images used as input provided no improvement com-
pared to polyenergetic image input with CMOS acquired images. Using the CMOS detector
and any method proposed in this work, we were able to determine the effective atomic number
with mean error less than 3% and relative electron density with mean error less than 5%. We
demonstrated that the CMOS detector outperformed the CCD detector for the determination of
effective atomic numbers and relative electron densities. The higher efficiency of the CMOS
detector allowed us to increase the beam filtration and harden the x-ray spectra more than we
could with the CCD. The combination of using polyenergetic images, CMOS detector, and the
empirical polynomial fit DECT image-space algorithm provided the best accuracy as well as
computational simplicity for the measurement of effective atomic number and relative electron
density.
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5.2 Summary of conclusions
In summary, we have created a small animal image-guided conformal radiotherapy platform
built upon a commercial micro-CT scanner gantry. This was achieved by 1) designing, build-
ing and commissioning a set of computer controlled asymmetric jaw collimators and 2) de-
signing and building a computer controlled beam filter wheel and replacement of the imaging
detector. A Monte Carlo dosimetry code was commissioned for dose calculations for this
micro-radiotherapy system. Finally, dual energy micro-CT was investigated for measuring the
effective atomic number and relative electron density of materials to improve dose computa-
tion accuracy. Beam hardening effects that limited the accuracy of dual energy micro-CT were
overcome by optimization of the dual energy spectra. Table 5.1 updates table 1.1 to include the
system developed in this thesis.
5.3 Limitations
One limitation of the system is the low dose rate of approximately 0.3 Gy/min. As the radio-
therapy platform developed in this thesis is based on a micro-CT, the diagnostic x-ray tube and
generator are not designed for therapeutic radiation dose rates. The low dose rate has both
practical and possible biological consequences. First, the low dose rate limits the number of
animals that can be treated in a day, making studies with many animals less appealing with
this system. Secondly, the low dose rate leads to long treatment times, during which cell re-
pair mechanisms can become active and counteract the biological radiation damage.18–21 These
limitations are not insurmountable, as the biological repair during long treatment times can be
counteracted with an increased dose prescription. When comparing studies conducted on this
system to that of other investigators, the dose rate effects will need to be considered. As for
the throughput of the system, many of the studies performed with the system have used few
animals as they undergo extensive time-consuming imaging. Respiratory-gated therapy does
not introduce an additional time penalty. As the duty cycle is approximately 10%, there is
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SARRP X-Rad 225Cx Stanford Western
(Johns Hopkins) (Toronto and University University
Masstricht) London, ON
Maximum 225 225 120 140
accelerating
potential (kVp)
Interchangeable Yes Yes No Yes
beam filters
Dose rate 4 4 2 0.3
(Gy/min)
Collimation Fixed cones Fixed cones Computerized Computerized
(Jaw option variable jaws
recently available) aperature
Field sizes Circular and Square Circular and Square Pseudo-circular Rectangular
0.5 mm  – 1.0 mm  – 0.1 – 6 cm  2 mm × 2 mm –
10 mm × 10 mm 10 mm × 10 mm 60 mm × 60 mm
Beam direction non-coplanar coplanar coplanar coplanar
Asymmetric/ No No No Yes
off-axis fields
Stage 3D + rotation 3D 3D (contrained SI computerized
translation by CT bore) AP manual
Respiratory No (Gated shutter No No Yes
Gating option recently ) (+ Cardiac)
available)
Image 130 200 49 68
resolution (µm)
Targeting 200 200 100 200–300
accurracy (µm)
Dose calculation Muriplan SmART-Plan RT Image BEAMnrc
and planning (Commericial) (Maastro Clinic, BEAMnrc Dose calc.
system Commercial) (Stanford, in-house) only
Table 5.1: Comparison of select image-guided small animal irradiation systems with the sys-
tem developed in this thesis.
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no need to reduce the duty cycle further for respiratory-gated therapy. The x-ray “on” time is
redistributed to occur within the gated window corresponding to end exhalation.
A second limitation is the treatment beam energy. At 140 kVp, the system is close to the
lower limit of preclinical systems, as most are operating at 225 kVp. The lower treatment
kVp means that photoelectric effects are more prominent and must be accounted for in the
computation of the dose distribution in the mouse. Bone dose enhancement must be considered.
The lower energy also has implications for physical dosimetry. Many dosimeters can have
energy dependent response at energies below 100 keV, including ion chambers and film. The
dose measurements used in this thesis were cross-calibrated against the LRCP local standard
ion chamber using calibration factors at 80 and 100 kVp. A second comparison with another
traceable standard would give increased confidence in the commissioning.
Soft tissue contrast is lacking in CT and the identification of an orthotopic legion by CT
alone will be difficult. To overcome this limitation in target identification using this system,
other imaging modalities, such as MRI, nuclear medicine, ultrasound or optical imaging will
be required.22,23
The Monte Carlo dose calculations shown in the thesis have been performed with single
energy CT information and simplified tissue segmentation. As discussed later, the change to
DECT based tissue segmentation for Monte Carlo dosimetry will improve the accuracy and
confidence in the dose calculations.
The phantom materials used in chapters 3 and 4 were not ideal. The composition of the
plastics are not well known and only approximate tissue atomic composition. The clinical
electron density inserts have known composition and reflect tissues, but are not sized appropri-
ately for a small animal system.
Finally, in chapter 4 the comparison of the CCD and CMOS detector may be biased, as
the CCD acquisition was not optimized to the same extent of the CMOS detector. The CCD
failed before we could perform such optimization, and was indeed the reason for acquiring the
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CMOS detector. The deficiencies in the accuracy of the results from the CCD detector cannot
be completely attributed to inherent limitations of the detector.
5.4 Future Work
A number of extensions of the thesis work are possible, with several described in this section.
5.4.1 CMOS detector
First, the installation of the CMOS flat panel detector has effectively created a new higher
performance micro-CT system. The imaging performance of this system has not been fully
characterized in terms of image quality. The previous configuration was characterized with the
vmCT phantom.24,25 A similar evaluation should be completed to determine parameters such
as the modulation transfer function (MTF) for this new scanner configuration. Additionally,
the set of imaging protocols needs to be updated and optimized for the new CMOS detector
configuration. The work of chapter 4 only examined optimizing scans for dual energy material
classification. Imaging protocols need to be developed and optimized for other simpler imaging
tasks with due consideration for animal dose reduction. Digital subtraction angiography (DSA)
has been successfully demonstrated in small animals, but has not been widely adopted.26 DSA
has been used to examine the tumour blood supply in small animals.27The framerate of the
previous CCD was too slow for dynamic studies and discouraged investigation of DSA with
this system. The 45 fps framerate of the CMOS flat panel provides a new opportunity to
implement DSA or tomographic DSA in small animals.
5.4.2 Small animal tissue characterization
As mentioned in the limitations above, the set of materials used for testing dual energy scanning
in chapters 3 and 4 were not ideal as tissue substitutes. A new set of phantoms should be
constructed from well-characterized materials with small dimensions appropriate for the micro-
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CT. The self-evident approach would be to scale down a clinical electron density phantom
composed of tissue mimicking plastics to the size of a rat and mouse. Following dual energy
calibration and verification on the appropriate phantom, a series of animal tissues should be
scanned to determine if human tissue composition estimates are appropriate for small animal
tissues. Ideally, independent measures of small animal tissue composition should be made to
corroborate radiological measures. Once small animal tissue compositions are analysed, they
can be implemented in the Monte Carlo dose calculation codes to improve dose calculation
accuracy. Furthermore, a dosimetry error budget needs to be investigated to determine the
level of accurracy required from the dose calculation. Then it will be possible to clearly define
the accuracy needed in the DEmCT measurements of effective atomic number and relative
electron density. For context, an error of 0.5 in effective atomic number leads to a local relative
dose difference of approximately 8% in dense bone, and 14% in soft tissues for the 140 kVp
therapy beam.
5.4.3 Inverse planning
The overall objective of this thesis was to develop preclinical radiation therapy to better match
clinical practice. One area that was not addressed in this thesis is inverse treatment planning.
A core part of IMRT is the ability of the planning system to determine the beam intensity
profiles based upon a number of clinical objectives. To date, treatment planning on dedicated
preclinical radiation therapy platforms is restricted to forward planning. In forward planning,
the planner chooses the beam shapes and weights. The jaws system developed in this thesis may
be more amenable to implementing inverse planning, as the jaws mirror the clinical machine,
and algorithms for jaw sequencing may be implemented.28,29
5.4.4 Gated radiotherapy
One benefit of the diagnostic x-ray generator and tube is the temporal control of the radiation
exposures. This allows gating of the delivery of radiation based on respiratory, or potentially
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cardiac, waveforms. Chapter 2 only demonstrated proof-of-concept for respiratory gating using
sinusoidal breathing patterns. Further investigations are possible to quantify how the system
performs with different respiratory waveforms. Cardiac motion may be more of a concern for
small animals comparted to humans due to the relatively larger size of the heart compared to
the lungs. The impact of cardiac motion on small animal thoracic tumours can uniquely be
investigated with cardiac gating available on this system. Moving beyond film, the motion blur
of the dose deposited could be measured biologically by mapping γ-H2AX staining in animals
irradiated with and without gating .
5.4.5 Potential preclinical studies
With the availability of the new micro-CT/RT radiotherapy system, a large variety of preclinical
irradiation studies are now possible. A few potential extensions to collaborative studies that
have used the system are discussed.
In collaboration with K. Thind et al., it was shown the number of macrophages are increased
in the lung following conformal irradiation with the micro-CT/RT.30 Lactate to pyruvate levels
in irradiated lung were found to be elevated as measured by C-13 MRI. Work to examine
these biological markers, and eventually determine mechanisms for the increase in macrophage
numbers and source of the elevated lactate to pyruvate levels is an area of potential interest.
Work into immunohistochemical staining of the macrophages to identify their activation state
is a possible companion avenue of exploration.
Studies of primary brain tumour or brain metastasis models have been performed using
this system. A pilot study with M. Cooper, S. Schmid and M. Hebb (unpublished) examined
combining radiotherapy with electric field therapy for glioma. The system developed in this
thesis allows for the imaging and targeting of the implanted electrode and surrounding tumour.
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5.5 Impact and Significance
A small animal conformal image-guided radiation therapy system has been built that addresses
some of the previous limitations of other similar systems available at the start of this thesis.
A computer controlled, asymmetric jaw collimator was designed, built and commissioned that
offers a major advancement over the manual collimators of other systems. Computerized col-
limation is a key component towards bringing Intensity Modulated Radiation Therapy (IMRT)
to the preclinical setting. Respiratory gating is another clinically available feature now made
possible in a preclinical radiotherapy systems. This thesis documents one of the first imple-
mentations of computerized asymmetric jaw collimation and respiratory gating on a dedicated
preclinical system. Finally, measuring effective atomic number and relative electron density
are crucial to accurate dose calculations with the kilovoltage energies used in small animal ra-
diotherapy. One of the first applications of dual energy CT techniques for measuring effective
atomic number and relative electron density to micro-CT is presented in this thesis. A pre-
clinical system that allows controlled studies of radiobiological response to radiation in vivo
using irradiation techniques similar to those achievable clinically will become a useful tool to
optimize biologically-driven treatment planning for future cancer patients.
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Appendix A
Film processing details
This appendix is adapted from the appendix of the research article, “Implementation and com-
missioning of an integrated micro-CT/RT system with computerized independent jaw colli-
mation”. Reprinted with permission from M. D. Jensen, W. T. Hrinivich, J. A. Jung, D. W.
Holdsworth, M. Drangova, J. Chen and E. Wong, Medical Physics 40, 081706 (2013).
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A.1 Film processing
Each film was scanned four times both before and after radiation exposure. In order to reduce
noise from a scanner warm-up effect, only the last three film scans were averaged for analy-
sis.1,2 To get dark field pixel values, an opaque sheet was scanned after each set of unexposed
and exposed film scans. The corrected net optical density, using the blue channel to account
for film thickness,3 was calculated as:
netODcorr =
ODexp,red − ODunexp,red
ODunexp,blue
=
log10
(
PVunexp,red−PV0,unexp,red
PVexp,red−PV0,exp,red
)
log10
(
216
PVunexp,blue−PV0,unexp,blue
) , (A.1)
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where ODexp,red, ODunexp,red, and ODunexp,blue are the OD measured in the red colour channel and
blue colour channel of the exposed and unexposed film. PV values are scanner pixel values
measured in the red and blue colour channel of exposed and unexposed film. PV0s are opaque
film pixel values for red and blue channels after scanning a set of unexposed films and a set of
exposed films.
To convert netOD to dose, eight 70 mm × 70 mm calibration films were prepared and
placed horizontally, at the isocenter of the micro-CT, between two 70 mm × 70 mm × 10 mm
solid water phantom blocks. An additional 2 mm of solid water was placed on top of the stack.
The jaws were set to give a 50 mm × 50 mm field size. The first films were exposed with 433
pulses, approximately equal to 0.5 Gy. Each consecutive film was exposed with an additional
433 pulses, compared to the previous one. This was repeated to give 8 total films, ranging in
dose from 0.5 Gy to 8 Gy, in steps of 0.5 Gy. Each film was scanned as stated above, and the
center 20 × 20 pixel region was averaged to give a single netOD value for each calibration film.
Dose per pulse, calculated from ion chamber measurements of identical geometry, was used to
calculate the dose given to each film. The dose as a function of netOD,1,2
Dfit = a + b · netOD + c · netODn, (A.2)
was fitted using ordinary linear regression. Different n values between 2 and 3 were tried to
find the best fit parameters.1
A setting of n = 2.4 resulted in the best fit of the calibration films. At n = 2.4, the three
coefficients were found to be a = 0, b = 3.43 ± 0.07, and c = 6.1 ± 0.2. The calibration curve
is shown in figure A.1.
We used the method described by Devic et al.1,2 to calculate the film dose error from the
spatial pixel variation of the film sampling area and the uncertainty in the calibration curve fit.
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The equation,
σDtot(%) =
√
netOD2 · σ2b + netOD2n · σ2c + (b + n · c · netODn−1 · σ2netOD)
Dfit
× 100, (A.3)
is derived by propagating the standard deviation from averaging the three scans through equa-
tion A.1. We found this method did not account for inter-film variability. We estimated the
inter-film variability by measuring the standard error of three measurements of each of the 50
× 50 mm2 and 40 × 40 mm2 fields. The composite error is computed by adding the intra-film
(σDtot) and inter-film error in quadrature. The estimate of the inter-film variability is about 3%,
as determined by repeated measurements. The intra-film variability is about 2%, and varies for
each digitized film pixel.
Figure A.1: EBT2 film calibration curve fit of film net optical density to dose. Size of marker
indicates standard deviation of netOD values.
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Appendix B
Dual energy algorithms
This appendix briefly describes the previously published dual energy algorithms applied in
chapters 3 and 4. The reader is encouraged to consult the primary references for a thorough
description of the algorithms.
B.1 Theoretical effective atomic number
In chapter 3 the empirical power law effective atomic number (Zeff ) is defined as
Zeff =
(∑
i
aiZni
) 1
n
, (B.1)
where Zi is the atomic number of the ith element in the mixture and ai the fractional number of
electrons belonging to the ith element in the mixture. The value for the parameter n was chosen
as 3.5. This is the definition published by Johns and Cunningham.1
In chapter 4 we use the empirical effective atomic number (Zmed) as defined by Bourque
et al..2 Briefly, a lookup curve is constructed using the NIST XCOM database3 to give the
electron cross section for all the elements from the atomic number, averaged over a specific
x-ray spectrum. Therefore the value of (Zmed) is dependent on the x-ray spectra. To find the
effective atomic number (Zmed) of any material, one calculates the electron cross section of the
material for the spectra of interest and uses the inverse of the atomic number to electron cross
124
Appendix B. Dual energy algorithms 125
section lookup curve function.
Zmed ≡ σˆ−1e (σe,med) (B.2)
B.2 Reduced Hounsfield unit
The Houndsfield unit is defined as
HU = 1000
(
µ
µw
− 1
)
, (B.3)
where µ is the linear attenuation coefficient of the material of interest, and µw the linear atten-
uation coefficient of water. The reduced Hounsfield unit is given by
µ j
µ jw
=
HU j
1000
+ 1, (B.4)
where j indicates energy of the scan (low or high).
B.3 Spectral based DECT method
The image space spectrum method by Bazalova et. al was implemented.4,5 This method was
based on the work by Torikoshi et al. for monochromatic energy scans.6 Additionally, the
improvements by Landry et al. were implemented– specifically the calculation of the effective
atomic number of water (Zw) using the x-ray spectra and attenuation coefficient data..7,8
The linear attenuation coefficient µ j, for an energy spectrum j, can be expressed as
µ j = ρe
∑
i
ω ji[Z4F(E ji,Z) + G(E ji,Z)], (B.5)
with ρe the electron density of the material, ω ji the weight of energy i in the spectrum j, Z the
effective atomic number and E ji the photon energy.
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The attenuation components are modelled with two empirically fit functions. The pho-
toelectric component ρeZ4F(E ji,Z), and the combined coherent and incoherent component
ρeG(E ji,Z). The functions F(E,Z) and G(E,Z) are produced by quadratic fits to the NIST
XCOM database.3 The effective atomic number (Z) of the material is found by solving
Z4 −
{(
µ2
µ2w
∑
i
ω2i[Z4wF(E2i,Zw) + G(E2i,Zw)]
∑
i
ω1iG(E1i,Z)
− µ1
µ1w
∑
i
ω1i[Z4wF(E1i,Zw) + G(E1i,Zw)]
∑
i
ω2iG(E2i,Z)
)/
(
µ1
µ1w
∑
i
ω1i[Z4wF(E1i,Zw) + F(E1i,Zw)]
∑
i
ω2iF(E2i,Z)
− µ2
µ2w
∑
i
ω2i[Z4wF(E2i,Zw) + G(E2i,Zw)]
∑
i
ω1iF(E1i,Z)
)
= 0
(B.6)
for each voxel. Equation B.6 was obtained by combining equations B.4 and B.5 at two ener-
gies. Using either the high or low energy scan ( j = 1,2), the relative electron density is then
calculated with
ρe/ρe,w =
µ j
µ jw
∑
i ω ji[Z4wF(E ji,Zw) + G(E ji,Zw)]∑
i ω ji[Z4F(E ji,Z) + G(E ji,Z)]
. (B.7)
For only in chapter 4, a linear correction was applied to the spectral method to reduce the
error between measured effective atomic number (EAN) and theoretical Zmed values.
B.4 Empirical polynomial fit DECT method
We implemented the method published by Bourque et al.2 Briefly, the dual energy ratio (DER)
is computed for each voxel of the image pair. The dual energy ratio (Γ = DER) is defined as
Γ ≡ µ1
µ2
, (B.8)
with µ1 and µ2 the reduced Hounsfield units of the voxel pair from the low and high energy
scans.
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A polynomial is fit to relate the theoretical effective atomic number Zmed to the DER for all
materials.
Zmed =
K∑
k=1
ckΓk−1 (B.9)
Then another two polynomials, one for each energy scan, are fit to relate the theoretical relative
electron density to the reduced HU and Zmed.
(ρe/ρe,w) j =
µ j∑M
m=1 b j,mZ
m−1
med
(B.10)
Both the high and low energy scans are used to compute two relative electron density maps
which are equally weighted to create a final relative electron density map.
ρe/ρe,w =
1
2
[
(ρeρe,w)1 + (ρe/ρe,w)2
]
(B.11)
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Appendix C
Study of the IMRT interplay effect using
4DCT Monte Carlo dose calculation
This appendix is adapted from the research article “Study of the IMRT interplay effect using
a 4DCT Monte Carlo dose calculation”. Reprinted with permission from M. D. Jensen, A.
Abdellatif, J. Chen and E. Wong, Physics in Medicine and Biology 57, N89–99 (2012).
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doi: 10.1088/0031-9155/57/8/N89
C.1 Introduction
Respiratory motion has the potential to negatively impact radiation therapy treatments if the
motion is not properly managed. This is especially true when more complex multileaf colli-
mator (MLC) patterns are used, such as in integrated boosts with IMRT and VMAT, which
are increasingly being deployed. These treatments can be susceptible to the interplay effect
between motion of the anatomy from respiration and multileaf collimators. The interplay of
the concurrent motion of the anatomy and multileaf collimator can lead to errors within the
treatment field.1–5
Dose calculation with patient motion has previously been studied by Litzenberg et al.,6
Oliver et al.,7,8 and Waghorn et al.9 using patient tracking information to move the beam
isocentre relative to the patient to simulate motion. Litzenberg et al. used position information
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from electromagnetically tracked implantable transponders, combined with a motion phantom,
MLC controller log files and Monte Carlo dose calculation to investigate intra-fraction motion.
Waghorn et al. modified the fluence maps in a treatment planning system by shifting them in
the opposite direction of the patient motion, using respiratory traces. However, these previous
studies did not employ four-dimensional computed tomography (4D CT).
With 4D CT, one allowed the possibility to incorporate tissue deformation into planning
and simulation. One method of 4D dose calculation is to calculate the same plan on all phases
of a 4D CT, and deform10 back to a reference scan.11,12 Flampouri et al.13 and Huang T-C et al.14
have combined this technique with Monte Carlo dose computations. However, this approach
does not permit accounting for interplay effects, and assumes the motion effects will uniformly
smear out over the course of many treatments.3,5,15
Several publications have used linear accelerator (linac) and multileaf collimator controller
log files to recreate volumetric modulated arc therapy (VMAT) deliveries. Schreibmann et al.16
and Haga et al.17 used the log files to modify the original treatment plan, so that the verification
dose calculation can be done in the original treatment planning system. Qian et al.18 used a
similar technique and combined it with cone-beam CT. Qian et al.19 subsequently extended
this technique to use the TrueBeam (Varian Medical Systems, Palo Alto, CA USA) system
trajectory log files to add respiratory motion data to verify respiratory gated VMAT. Teke et
al.20 has combined log files with a Monte Carlo dose engine as a basis for a patient-specific
VMAT QA system.
These previous studies have made use of selected data sources and techniques, such as linac
log files, respiratory trace log files, 4D CT, and Monte Carlo dose engines in their dose com-
putations. To the authors’ knowledge, no previous studies combine all these data sources and
techniques to build a delivery reconstruction simulator. By using motion data of both the patient
and the linac recorded during treatment and performing Monte Carlo dose computations on 4D
CT, we can simulate the delivered dose with less assumptions regarding machine performance
or patient breathing and be able to examine the impact of making various simplifications.
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In this paper, we extend the isocentre shifting method7,8 to utilize 4D CT in addition to the
linac log files and respiratory motion tracking information to reconstruct the dose delivered to
a rigid phantom from a 3D step-and-shoot IMRT plan. Many publications have included de-
formable registration to warp the doses back to a base phase scan.11–14,21 In this study, we have
purposely omitted patient/phantom deformation to examine dose computations alone, without
effects confounded by deformable dose warping. This approach cleanly separates 4DCT dose
simulation and deformable registration, allowing independent verification, and integration in
the future.
C.2 Methods
We began with a 3D step-and-shoot IMRT plan registered to one phase of a 4D CT. The plan
was then delivered to a phantom, and the linac and respiratory log files were collected. Res-
piratory motion was initially modeled by moving the plan isocentre on the one phase of the
4D CT using the respiratory log file. This isocentre shifting method was previously validated
with measurements.7,8 To extend the method to 4DCT dose calculation, we replace the isocen-
tre shift by picking the phase of 4D CT corresponding to the respiratory motion. Dose was
computed using a Monte Carlo method with MLC positions during the delivery determined by
the linac log files. The doses to the different respiratory phases were combined to give a total
dose distribution.
First, we compared our 4DCT method to the isocentre shifting rigid phantom method, pre-
viously validated against measurements.7,8 Secondly, we investigated the effect of the limited
sampling of motion in 4DCT. The isocentre shifting method can finely sample the phantom
motion, and the result is limited by the dose calculation grid resolution. However, 4D CT ef-
fectively limits the motion sampling to 10 positions. Thirdly, we examined two gating cases,
which further reduce the sampled positions from 4D CT. Finally, we compared our time ex-
plicit motion simulations with time and position weighted average 4D dose calculations, using
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either parameters from the linac log file or DICOM RT plan. The purpose of these comparisons
is to find out the limitations of various approximations in 4D dose calculations, especially time
and position averaged 4D-dose calculation methods available in some commercial treatment
planning systems.
A respiratory motion phantom was scanned using 4D CT, and two step-and-shoot 3D IMRT
plans were transferred to the CT images at the end-of-expiration (EOE) phase. The 3D IMRT
plans were delivered to the moving phantom, both with and without gating. The respiratory
trace and linac/MLC controller log files were collected from the deliveries of the 3D IMRT
plans. The log files were synchronized in time and combined with the 4D CT to reconstruct
the delivered dose using a Monte Carlo dose calculation engine.22 This simulation reconstructs
the time series of events during the treatment. Three methods of motion reconstruction were
used: continuous shifting of the beam isocentre on the EOE phase, discrete shifting of the beam
isocentre on the EOE phase and using the full 4D CT. These methods are named continuous
isocentre shift, discrete isocentre shift and 4DCT. The 4DCT method is illustrated in figure C.1.
Additionally, two simulations without the explicit time series of events were completed. Both
methods simulate the full delivery of the 3D IMRT plan on each of the ten phases of the 4D CT;
dose to each phase is weighted by 10% and they are added together to get a time and position
averaged total dose. The difference between the two methods is that the first uses the linac
log file for MLC positions and segment weights, while the second uses the MLC and segment
weights from the RT plan file. These two methods are referred to as 4DCT Delivery Average
and 4DCT Plan Average. All simulation methods were compared against the gold standard
continuous isocentre shift method.
C.2.1 Phantom, contours, IMRT plan and 4DCT acquisition
A rigid respiratory motion phantom (QUASAR Respiratory Motion Phantom, Modus Medical
Devices Inc., London, ON Canada) (figure C.2) was imaged using the 4D Thorax protocol on a
Brilliance CT Big Bore Oncology scanner (Philips Healthcare, Andover, MA USA) equipped
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Figure C.1: Overview of the 4D CT with respiratory and MLC position data simulation. Gated
delivery is shown. Linac and respiration log files are synchronized in time using the beam on
and beam enable flags. The delivery is then divided into 400 ms samples (dashed boxes),
containing linac state and patient respiratory information. Each of the samples is matched with
the appropriate 4DCT phase image using the patient respiration phase information. Each time
sample containing delivered MU is then simulated using the Monte Carlo dose computation.
The series of dose matrices are then registered back to the base phase of the 4DCT scan, and
summed to obtain the total dose. Areas of the beam enable/beam on graph where the gating
window is open but no MU are delivered, are locations where the leaves are repositioning for
the next IMRT segment.
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Figure C.2: End of Inhale (EOI) CT scan of 1D motion phantom in axial (a), sagittal (b) and
coronal (c) view with contours for the concave target. Photograph of 1D motion phantom (d).
with a respiratory position management system (Varian Medical Systems, Palo Alto, CA USA).
The thorax protocol produces 10 image sets equally spaced throughout the respiratory cycle.
The phantom was programmed to move with regular sinusoidal motion, with amplitude of
2 cm (peak to peak) and period of 4 seconds. Two 3D IMRT step-and-shoot plans, the first for
a concave target,7,8 and the second a integrated boost plan (to fit into the moving part of the
phantom, we used a prostate plan with a dominant intra-prostatic legion boost), were copied to
the 4D CT end-of-expiration (EOE) scan using a treatment planning system (Pinnacle3 v8.0m
Philips Medical Systems, Fitsburg, WI, USA). The first concave target plan consisted of 5
beams using step-and-shoot delivery with 30 segments and 592 MU. The second integrated
boost plan had 5 beams using step-and-shoot delivery with 50 segments and 553 MU.
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C.2.2 Delivery of treatment
The IMRT plans were delivered to the respiratory phantom as described by Oliver et al.8 The
treatments were delivered using a linear accelerator (Clinac 21EX, Varian Medical Systems,
Palo Alto CA USA) configured with a 120 leaf MLC and real time position (RPM) monitoring
system. Each plan was delivered three times; no gating, 50% duty cycle gating and 25% duty
cycle gating. There was no attempt to synchronize the start of the treatment with the respiratory
motion for the ungated delivery.
C.2.3 Simulation of treatment
Five simulation types were performed in this work. The first three methods, continuous isocen-
tre shift; discrete isocentre shift and 4DCT (figure C.1), reconstruct the delivery with explicit
simulation of the motion of the phantom and linear accelerator in time. The log files from the
experimental delivery were combined with the 4DCT scan to reconstruct the treatment time
course in discrete time samples. These time samples were fed into a Monte Carlo dose cal-
culation engine, and the resulting dose matrices summed. The last two methods, 4DCT plan
average using planning segment weights and MLC positions and 4DCT delivery average using
dynamic MLC log (dynalog) files for delivered segment weights and MLC positions, simu-
late the full delivery to each of the 10 phases of the 4D CT and produce a time and position
averaged dose.
C.2.3.1 Log file processing
The IMRT delivery produces two dynamic MLC log files sampled at a frequency of 50 ms
that record the motion of both leaf banks, the running fraction of MU output, and the beam
on status. The RPM system logs the relative position of the IR reflector box, as well as beam-
enable flags and current phase of the motion with a frequency of 33 ms.
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Log file processing was performed with custom written software developed in MATLAB
(The Mathworks Inc, Natick, MA, USA). The log files were synchronized in time by matching
the beam on and beam enable flags (figure C.1). The logs were then divided into time step
samples of 400 ms or less to be used for Monte Carlo dose calculations. Each Monte Carlo
time sample contains the MU delivered, the positions of the leaves and jaws, the position of the
phantom IR reflector and the current phase state of the phantom. A Monte Carlo time sample
will be less than 400 ms, if the MUs for that segment have all been delivered before the end
of a 400 ms time sample, or if a gating beam hold occurs within a 400 ms time sample. The
Monte Carlo time sample phantom position is the average position during the time sample,
while the Monte Carlo time sample phantom phase is the phase sampled at the middle of the
time sample.
C.2.3.2 4DCT image phases
The RPM phase recorded in the Monte Carlo time sample was used to select the appropriate
phase of the 4DCT for the dose calculation.
The 10 phases of the 4D CT were registered to each other by plotting a CT number profile
though the moving cylinder. The position of the full width at half max for each profile was used
to calculate the superior-inferior offset for each of the phases relative to a base phase. These
offsets were used to combine the 10 dose grids corresponding to the 10 respiratory phases
without the need of deformable registration software. Additionally, these offsets were used to
perform the discrete isocentre shift calculation.
C.2.3.3 Monte Carlo dose calculations
The dose for each time sample was calculated using a fast Monte Carlo method (Numerix
v1.12, Numerix LLC, New York, NY, USA) with 3 mm isotropic dose grid.22 Each time sample
simulation used 100,000 photon histories, with variance reduction performed on each sample.
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C.2.4 Analysis
The image and dose data was visualized in the Computational Environment for Radiotherapy
Research (CERR).23 A dose region measuring 6.0 × 6.0 × 13.8 cm from the center of the
moving portion of the phantom was used to compare six calculation methods. The gamma
method,24,25 extended to 3 dimensions, was used with agreement criteria of 2%, 2 mm. The
dose distributions were interpolated to 0.2 mm isotropic resolution for the gamma analysis.
The discrete isocentre shift, 4DCT, 4DCT delivery average and 4DCT plan average dose dis-
tributions were compared against the gold standard continuous isocentre shift method.
Gamma analysis is a well known metric to quantify the dose distribution differences and
was chosen to compare the calculation methods. While gamma analysis has been recently
criticized as a clinical QA tool,10,26,27 we feel it appropriately meets the needs of this study.
C.3 Results
Coronal dose distributions, dose difference, and 3D gamma map planes for the concave tar-
get and integrated boost plan for the five simulation methods of the ungated motion cases are
shown in figures C.3 and C.4. Table C.1 shows the 3D gamma analysis passing percentages and
mean gamma values for all the simulations compared to the gold standard continuous isocentre
shift method. The 3D gamma passing percentage analysis indicates that the discrete isocentre
shift and 4DCT methods of simulation are equivalent to the previously validated continuous
isocentre shift method, with greater than 99% of points passing the 2% 2 mm gamma threshold
for both plans and for all gating conditions. For the time and position averaged simulations,
the results are plan and gating dependent. The plan with concave target showed negligible dis-
agreement with the gold standard continuous isocentre shift method. However, the integrated
boost plan only had an 80% passing percentage for the 4DCT delivery and plan averaged sim-
ulations at 2%, 2 mm. Relaxing the gamma pass criteria to 3%, 3 mm improved the passing
percentage to 93.6% for the 4DCT delivery average simulation, and 93.1% for the 4DCT plan
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Integrated boost plan Concave target plan
Gating Simulation type Pass per cent Mean gamma Pass per cent Mean gamma
No gating Discrete isocentre shift 100 0.19 100 0.17
4DCT 100 0.20 100 0.18
4DCT delivery average 80.7 0.54 99.2 0.23
4DCT plan average 80.3 0.54 98.4 0.25
Gating 50% Discrete isocentre shift 100 0.20 100 0.18
4DCT 100 0.19 99.9 0.19
4DCT delivery average 100 0.13 100 0.26
4DCT plan average 99.4 0.21 99.7 0.28
Gating 25% Discrete isocentre shift 100 0.12 100 0.11
4DCT 100 0.11 100 0.13
4DCT delivery average 100 0.12 100 0.11
4DCT plan average 99.8 0.19 100 0.16
Table C.1: 3D Gamma analysis (2%, 2 mm) comparing 4D methods to gold standard contin-
uous isocentre shift method.
average simulation. When gating was applied, this disagreement disappeared for the integrated
boost plan, indicating gating reduced IMRT interplay effects significantly. The difference in
gamma for the time and position average simulation doses, between the planned and actual leaf
positions and segment weights, was less than 1% for all cases examined.
C.4 Discussion
Our study demonstrated that our 4DCT simulation using delivery log files is consistent with our
previously validated isocentre shift method for the two cases examined with rigid 1D motion.
Constraining the isocentre to ten positions of 4D CT did not noticeably impact the dose for the
two cases examined.
This study showed the IMRT interplay effect can be significant for a single fraction of a 3D
step-and-shoot IMRT plan. However, this is plan dependent, as the integrated boost plan was
more sensitive to time averaging than the concave target plan. This work did not examine the
effect of multiple fractions, and if a series of repeated time explicit simulations would converge
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Figure C.3: Coronal plane dose distributions for the concave target plan: a) no motion and b)
continuous isocentre shift. Coronal plane dose difference between: c) discrete isocentre shift;
d) 4DCT; e) 4DCT delivery average; f) 4DCT plan average; and continuous isocentre shift.
Coronal plane of 3D gamma map (2%, 2 mm) between: g) discrete isocentre shift; h) 4DCT; i)
4DCT delivery average; j) 4DCT plan average; and continuous isocentre shift.
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Figure C.4: Coronal plane dose distributions for the integrated boost plan: a) no motion and b)
continuous isocentre shift. Coronal plane dose difference between: c) discrete isocentre shift;
d) 4DCT; e) 4DCT delivery average; f) 4DCT plan average; and continuous isocentre shift.
Coronal plane of 3D gamma map (2%, 2 mm) between: g) discrete isocentre shift; h) 4DCT; i)
4DCT delivery average; j) 4DCT plan average; and continuous isocentre shift.
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to the time and position averaged simulation. Both a 50% and 25% gating window strongly
reduced the interplay effect for the integrated boost plan.
This work only examined simplistic one-dimensional, rigid, sinusoidal motion. The re-
sults of this study cannot be blindly generalized to three-dimensional, deforming, and irregular
motion. However, the 1D motion is a subset of 3D motion, and may be a reasonable approxi-
mation of some patients. With more complex motion, there is both the possibility of increased
or suppressed interplay effects, and more study is needed. This simulation framework is not
inherently restricted to one-dimensional motion. The addition of an advanced motion phan-
tom and deformable registration to our simulation framework would allow the study of more
complex motion.
This work illustrates how one may investigate the impact of different assumptions - with
and without log files, using the same plan on all phases of 4DCT, etc. It demonstrated that
our simulation framework is a useful tool to further study motion related effects. Combined
with deformable registration, this technique could be used to reconstruct the dose delivered to
patients.
The mean gamma was reported to give a metric of where the bulk of the gamma value
population lies, and the proximity to the pass threshold. The mean gamma can differentiate the
100% passing rates of the 50% and 25% duty cycle gating simulations. Reducing the gating
duty cycle from 50% to 25% resulted in approximately a 50% reduction in the mean gamma.
Gamma analysis has come under scrutiny as a metric for examining the clinical impact of dose
distribution changes.10,26,27 However, in this work, we are using the gamma technique to only
quantify the change in the dose distribution for different simulation techniques. We are not
suggesting these results should be applied to clinical practice
Appendix C. IMRT interplay effect using a 4DCT MC dose calculation 142
C.5 Conclusion
We have developed a 4DCT Monte Carlo simulation method to account for IMRT interplay ef-
fects with respiratory motion. The method is consistent with our previously validated isocentre
shift simulation work. Using linac log files, real-time position management log files and 4D
CT, we showed that the IMRT interplay effect caused a single fraction dose to differ from the
time and position averaged dose for a 3D IMRT integrated boost plan. This work provides a
tool for studying the IMRT interplay effect.
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Appendix E
Animal Ethics Approval
This thesis contains small animal experimental data. The ethics approval of the Animal Use
Protocols (AUP) is provided in this appendix.
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AUP Number: 2012­039
PI Name: Wong, Eugene
AUP Title: A Pilot Study Of Targeted Irradiation In Rats
Approval Date: 03/28/2013
Official Notice of Animal Use Subcommittee (AUS) Approval: Your new Animal Use Protocol (AUP)
entitled "A Pilot Study Of Targeted Irradiation In Rats" has been APPROVED by the Animal Use
Subcommittee of the University Council on Animal Care. This approval, although valid for four years,
and is subject to annual Protocol Renewal.2012­039::1
1.  This AUP number must be indicated when ordering animals for this project.
2.  Animals for other projects may not be ordered under this AUP number.
3.  Purchases of animals other than through this system must be cleared through the ACVS office.
Health certificates will be required.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety components
(biosafety, radiation safety, general laboratory safety) comply with institutional safety standards and have
received all necessary approvals. Please consult directly with your institutional safety officers.
Submitted by: Copeman, Laura 
on behalf of the Animal Use Subcommittee
University Council on Animal Care
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2009­080::5:
AUP Number: 2009­080
AUP Title: Non­Invasive Imaging of Metastasis: Detection, Monitoring and Intervention
Yearly Renewal Date: 11/01/2014
The YEARLY RENEWAL to Animal Use Protocol (AUP) 2009­080 has been approved, and will be
approved for one year following the above review date.
1.  This AUP number must be indicated when ordering animals for this project.
2.  Animals for other projects may not be ordered under this AUP number.
3.  Purchases of animals other than through this system must be cleared through the ACVS office.
Health certificates will be required.
REQUIREMENTS/COMMENTS
Please ensure that individual(s) performing procedures on live animals, as described in this protocol, are
familiar with the contents of this document.
The holder of this Animal Use Protocol is responsible to ensure that all associated safety components
(biosafety, radiation safety, general laboratory safety) comply with institutional safety standards and have
received all necessary approvals. Please consult directly with your institutional safety officers.
Submitted by: Kinchlea, Will D 
on behalf of the Animal Use Subcommittee
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